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ABBREVIATIONS  
ΔΨm Metabolic membrane potential 
ALT Alanine aminotransferase 
ANOVA Analysis of variance 
AST Aspartate aminotransferase  
ATP Adenosine-triphosphate 
BW Body weight 
CLS Cell line service 
CRP C-reactive protein 
DFU Diabetic foot ulcer 
DMEM Dulbecco's modified eagle medium 
DMSO Dimethyl sulfoxide 
ECM Extracellular matrix 
EDTA Ethylene-diamine-tetra-acetic acid 
FACS Fluorescence-activated cell sorting 
FBS Fetal bovine serum 
FGF Fibroblast growth factor 
GSEA Gene set enrichment analysis 
GLDH Glutamate dehydrogenase 
HaCaT Immortalized human keratinocytes 
H&E staining Haematoxylin and eosin staining 
IL Interleukin 
IR Infrared 
KEGG Kyoto encyclopedia of genes and genomes 
LED Light emitting diode 
LLLT Low-level light therapy 
MMF Midazolam medetomidine fentanyl 
NES Normalized Enrichment Score 
NF-κB Nuclear factor of kappa light polypeptide gene enhancer
 in B cells 1 
NaCl Sodium-chloride 
NHDF Normal human dermal fibroblasts 
PBM Photobiomodulation 
PBS Phosphate buffered saline 
PDGF Platelet-derived growth factor 
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PFA Paraformaldehyde 
ROS Reactive oxygen species 
TNF Tumor necrosis factor 
UV Ultraviolet 
VIS Visible light 
XTT Sodium 3´-[1-(phenylaminocarbonyl)-3,4-tetrazolium] 
 bis(4-methoxy-6-nitro)benzene sulfonic acid hydrate 
ZDF fa/+ Zucker diabetic fatty rat – healthy non-diabetic control 
animal (heterozygous) 
ZDF fa/fa Zucker diabetic fatty rat – diabetic animal (homozygous) 
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1 INTRODUCTION 
 Human skin 1.1
The human skin consists of three layers: epidermis, dermis and hypodermis 
(subcutaneous fat) (Figure 1). 
 
Figure 1: Structure of the human skin consisting of the epidermis, dermis and subcutaneous fat 
1
. 
Thin, hairy skin makes up 90% of the body’s surface, while the remaining 10% are 
covered by thicker, glabrous skin, which contains more sensory neurons to be able to 
perform delicate tasks 1. The outermost layer, the epidermis, protects the organism 
against chemical, biological and mechanical harm. It prevents water loss, while 
simultaneously acting as a barrier for pathogens of microbial or chemical nature 2-4. 
The epidermis is separated from the underlying dermis by the basement membrane, 
which is linked to the dermis by short fibrils 5. The vascularized dermis is composed 
of connective tissue consisting of collagen and elastin, where structures such as hair 
follicles, nerve endings, sebaceous and sweat glands are embedded 1, 6. Various 
types of nerve endings make it possible to distinguish between sensations such as 
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heat, itching, pain and pleasure 1. Sebaceous glands surround hair follicles and 
produce sebum, which is a fatty material keeping skin and hair soft and pliable. 
 
Figure 2: Detailed structure of the epidermis and 
dermis and its cells. The maturation of basal cells is 
shown and how they move from the stratum basale up 
to the stratum corneum
1
. 
Below the dermis lies the 
subcutaneous fat or hypodermis. Its 
purpose is to insulate the organism by 
retaining body heat while 
simultaneously protecting against heat 
from the environment. Small blood 
vessels in the dermis have their origin 
here, where the major blood vessels 
that supply the skin lie 5.  
The detailed structure of the skin and 
which cells are present in the different 
layers is shown in Figure 2. The 
epidermis mainly consists of 
keratinocytes that have their origin in 
the stratum basale. Here, basal cells 
are dividing continuously, maturating 
and becoming keratinocytes. 
Melanocytes are also present in the 
stratum basale, where they produce 
melanin, causing skin pigmentation. In 
case of DNA damage by UV 
irradiation, melanocytes can turn into 
skin cancer, known as melanoma 
cells. By dividing continuously, basal 
cells push newly matured 
keratinocytes upwards to the surface 
of the skin. In the stratum spinosum 
keratinocytes accumulate, producing 
keratin. Keratin makes the skin water-
proof and gives it strength and 
firmness. 
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Langerhans cells, located in the stratum spinosum, can react to allergens of microbial 
infiltration, which are bound to epidermal proteins 7.  
The further upwards keratinocytes move the flatter and more keratinized they are 
becoming. Because of the increasing distance from the vascularized dermis, they 
start to lack nutrients and slowly die 5. Due to the increasing amount of keratin, the 
stratum granulosum is a water-proof barrier. The stratum lucidum is what defines 
thick, glabrous skin, which can only be found on the palms and soles 1, 5. The stratum 
corneum is the outermost layer of the epidermis and completely consists of flat dead 
cells. The cells structures cannot be distinguished and are not nucleated anymore 
and eventually they shed 5. 
In addition to providing elasticity through collagen secretion by fibroblasts 8, the 
dermis also provides immunological defense against microbial invasion. Mast cells 
recognize pathogenic antigens and activate other immune cells through chemical 
signals. T cells act as an immunological memory and can react faster to known 
pathogens. Dendritic cells absorb antigens and can in turn activate other immune 
cells. Macrophages digest cell debris of destroyed microbes. 
 Wound healing 1.2
When skin integrity is impaired by physical injury, chemical or biological harm, 
precisely orchestrated mechanisms take place. They are separated into 
hemostastis/inflammation phase, proliferation phase and remodeling phase. They are 
sequential but include overlapping mechanisms 9.  
In the first phase hemostasis leads to the formation of a fibrin clot. It serves as a 
scaffold, but also attracts inflammatory cells by the release of chemokines and 
growth factors from degranulating platelets 10, 11. Neutrophils cleanse debris and 
bacteria and in turn macrophages facilitate phagocytosis of the remains 12. They 
release growth factors and cytokines (IL 1, IL 6, TNFα, FGF2) activating fibroblasts to 
proliferate and form a provisional matrix 13, thereby initiating the proliferative phase. 
Keratinocytes close the epidermis by migration from the margins and using the matrix 
as support. The extracellular matrix containing proteoglycans, collagen and elastin 
form a granulation tissue and replace the fibrin clot 14.  
In the last phase of wound healing the granulation tissue is remodeled. Here, new 
cells are produced while existing cells are removed by apoptosis. The extracellular 
Introduction 
6 
matrix is degraded and immature type III collagen is replaced by mature type I 
collagen 15, 16.  
1.2.1 Impaired wound healing and scar formation 
Sometimes normal repair mechanisms cannot be executed. This can lead to the 
development of chronic wounds, which are defined by persistent wounds that do not 
or heal only slowly in an extensive period of time. This leads to barrier defects and 
structural and functional integrity cannot be restored 17. Mainly, there are three major 
types of chronic wounds, which are divided by their cause of origin: Vascular 
insufficiency (venous leg ulcers), diabetes mellitus (diabetic foot ulcer (DFU) and high 
local pressure (pressure ulcers) 13. They are defined by nonmigratory epidermis, 
persistent inflammation, presence of infection, and biofilm formation. Underlying 
causes for diabetic foot ulcers are atherosclerotic diseases. Arterial blood supply is 
reduced, which causes tissue hypoxia and therefore damage. False or lack of 
medication can further contribute to the formation of DFUs, as small vessels and 
tissue can be damaged by hyperglycemia 18. Diabetes is often a cause of obesity, 
where hyperlipidemia adds to the existing conditions. The morbidity and mortality for 
these conditions are quite high, as 15% of diabetes patients will develop a foot ulcer. 
Even treated chronic wounds often result in amputation of which the 5-year mortality 
rate is around 50% 19.  
All of these conditions lead to an imbalanced immune response, where inflammatory 
and anti-inflammatory responses are misbalanced 13, 20. Studies show that 
proinflammatory cellular infiltrates lead to delayed wound healing. Proinflammatory 
cytokines as IL-1β and TNFα are deregulated and therefore prolong the inflammatory 
phase 21, 22. This leads to elevated metalloproteinases which degrade the ECM of the 
wound site and impair migration 23.  
The other side of impaired wound healing are a hyperproliferative epidermis which 
can cause hypertrophic scars or keloids. It contains thick collagen fibers which 
extend beyond the margins of the tissue damage 13. They are characterized by highly 
inflammatory processes, up-regulated fibroblast activity and excessive ECM 
deposition 24. Hypertrophic scars are usually self-limited and are more of a cosmetic 
concern than a severe disease 25.  
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1.2.2 Therapies to improve wound healing 
As obesity is becoming a global epidemic, chronic diseases as type 2 diabetes are a 
common consequence 26. By the implied rise of chronic wounds, development of new 
strategies for chronic wound management is essential.  
First interventions are always the application of wound dressings. They protect the 
open wound from contaminations while providing moisture and absorbing excess 
exudate. They can have antibacterial properties or stimulate cells to proliferate and 
migrate or induce matrix deposition 13. Current popular dressings are hydrocolloid 
dressings, which can trap fluid and are occlusive, but cannot be used for infected 
wounds. Hydrogels with integrated therapeutics can also rehydrate wounds, but may 
cause over-hydration 27. Wound dressings, while helpful, have limitations and have 
only a small impact on enhancement of chronic wound healing.  
Topical application of growth factors, especially platelet-derived growth factor, was 
attempted and had positive effects on wound healing, but only to a small extent 28-30. 
In contrast to other methods, this therapy seems to focus only on one factor. While 
growth factors are reduced in chronic wounds, many more molecules come into play 
and it seems unlikely that by replacing one of them all of the processes can be 
brought back to normal 27. 
Cellular products are widely used in regenerative therapies. They are not only used 
for chronic wounds, but also burns can be treated with allogeneic grafts. Epidermal 
keratinocytes are cultured and rapidly expanded using a feeder layer of murine 
fibroblasts 31. They have been shown to be quite effective, but are expensive and 
pose a risk of infection, also only a limited number of clinical trials exists 27, 32. 
Non-conventional therapies include negative pressure wound therapy. Negative 
pressure is applied by a device to optimize blood flow and remove exudate. 
Apparently, a reduction of wound edema and stimulation of granulation tissue 
formation adds to the advantages of this therapy. Studies showed that wounds 
treated with negative pressure, have reduced rates of infection from gram-negative 
bacteria 33. 
1.2.3 Photobiomodulation 
Photobiomodulation (PBM), also known as low level laser therapy (LLLT), is a non-
pharmacological and non-invasive strategy 34-39 to tackle different medical conditions 
including wound healing. Here, non-ionizing light in the visible or near-infrared 
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spectrum is used at a relatively low irradiance. While heat is produced, the 
mechanism of action does not include thermal effects, but rather rely on the 
absorption of photons by chromophores. Effects include neuroprotective responses, 
improvements in metabolism, blood flow and neurogenesis while decreasing 
inflammation and oxidative stress 40. 
One of the first medical benefits of PBM was discovered in 1967, when E. Mester 
tried to cure malignant tumors in rats with a ruby laser, by repeating an experiment of 
McGuff 41. As the power of the laser was too low, he was not successful in curing the 
tumors, but noticed enhanced hair growth and improved wound healing of the 
irradiated area 42, 43. Since then, many applications of PBM have been found. It is 
widely used in the treatment of back pain 44 and wounds 45. Blue light has been used 
against neonatal jaundice for over 60 years, firstly discovered by Cremer et al. 46, 47, 
who showed that bilirubin in neonates could be reduced 48-50. The use of PBM is also 
investigated for treating neurological conditions, including traumatic brain injury and 
neurodegenerative diseases as Alzheimer’s and Parkinson’s disease 51-57. 
PBM finds application also for cosmetic purposes such as acne treatment and 
improvement of scarring 58, 59, decreasing severity of wrinkles 60 and regrowing 
hair 61. 
As PBM is seen as a strategy in regenerative medicine, it also found applications in 
sport sciences. While treatment with mostly red and infrared light can improve muscle 
strength and therefore performance, it can also be used to prevent muscle damage 
after excessive exercise 62-65. 
 
As a light source, lasers or light emitting diodes (LEDs) are used. They are either 
employed in continuous or pulsed modes. The wavelength is an important 
characteristic, where blue light in the range of 400 – 450 nm is mostly used against 
neurologic conditions and with anti-inflammatory purposes. Red and infrared light in 
the spectrum between 600 – 690 nm and 700 – 900 nm are used against 
inflammatory diseases and for treatment of muscle tissue. Important parameters are 
the irradiance or power density (mW/cm²) which should not exceed a certain 
threshold, otherwise thermal effects would overshadow the photochemical processes 
and could result in burns. The irradiation time is also an aspect that should not be 
neglected, as together with the irradiance it defines the fluence or energy density 
(J/cm²). All in all these three factors are prone to errors, as outcomes rely heavily on 
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their precise adjustment. Effects can vary strongly if for instance the overall fluence is 
the same, but irradiance and irradiation time are adjusted. The typical biphasic dose-
response curve of PBM is the reason for this. While one dose can trigger certain 
effects, another dose with the same wavelength and irradiance can trigger the 
contrary. This follows the ‘Arndt-Schulz Law’ which states that weak stimuli 
accelerate cell activity, whereas stronger stimuli suppress it 66, 67.  
 
The first law of photochemistry states that light or photons must be absorbed by 
photoacceptors for photochemistry to occur. If a certain wavelength is not absorbed 
by anything in the tissue, no photobiological effects can be triggered 68, 69. 
Light of the VIS and NIR spectrum was shown to be absorbed by the respiratory 
chain molecules in mitochondria, for instance cytochrome C oxidase. This leads to an 
increased metabolism  and by signal transduction other effects are triggered 68. 
The main mechanisms in the signal transduction of photoacceptors changed by light 
were identified. The metabolic membrane potential (ΔΨm) is affected by VIS and IR 
light and stimulates ATP synthesis and the consumption of O2 
70-72. A misconception 
that ROS are only damaging by-products of respiration could be revealed. 
Mitochondrial ROS was found to be important for cellular signaling, including 
retrograde mitochondrial signaling 73-76. Broadband radiation was found to increase 
mitochondria-derived ROS formation and caused an increase of intracellular redox 
potential 77. Further, an increase in Ca2+ could be measured after irradiation with VIS 
light, which was released by affected mitochondria 78. The interplay of Ca2+, ΔΨm 
and ROS trigger several pathways to be up-regulated, including NF-κB 79, c-fos 80, 
DNA and RNA synthesis 81.  
 Aim of the study 1.3
The aim of the project was to test, whether the effects of photobiomodulation with 
blue light that were identified for keratinocytes and fibroblasts, also hold true for co-
cultures consisting of both of the cell lines. The effects on metabolic activity and 
proliferation should be determined for low dosages (10.35 J/cm²), where an increase 
for both cell lines was already proven in mono-cultures 82, 83. Also higher dosages 
(41.40 J/cm²) that cause an inhibitory effect should be investigated concerning these 
aspects.  
Introduction 
10 
After these effects were proven in vitro, these experiments should be translated to in 
vivo studies. Here, short and long-term effects were analyzed with the addition of a 
fluence of 82.80 J/cm², which was found to inhibit bacterial growth. The analysis in 
vivo should give results on whether an impairment of wound healing is taking place.  
Further, the findings were translated to the application of a portable device. The 
device had to be tested on its efficacy and safety for irradiation of patients. Therefore 
temperature development was tested on porcine skin.  
Key questions of the project are: 
 
- Does blue light irradiation have the same effects on co-cultures as it has on 
mono-cultures of keratinocytes and fibroblasts? 
 
- Can results found in cell culture be translated to animals and what are the 
effects on wound size, plasma parameters, histology and gene expression 
after single irradiations of different fluences? 
 
- Is it possible to develop a stable animal model for diabetes? 
 
- Does blue light irradiation affect the wound size of diabetic animals? 
 
- Which long-term effects does blue light cause, regarding plasma, histology 
and gene expression? 
 
- If a portable device for the treatment of chronic wounds can be developed, is 
its efficacy and safety ensured? 
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2 MATERIALS AND METHODS 
 Material list 2.1
2.1.1 Substances 
Description Manufacturer 
Fentanyl citrate Janssen Cilag 
Fetal Bovine Serum (FBS), heat-inactivated Life Technologies 
Fibroblast Growth medium 3 SupplementMix PromoCell 
Fibroblast Growth medium 3 SupplementMix, 
serumfree 
PromoCell 
Isoflurane CP-Pharma 
Ketamidor (Ketamine) WDT 
Midazolam (Midazolam) Ratiopharm 
Penicillin-Streptomycin Thermo Fisher Scientific 
Phosphate buffered saline (PBS)  Life Technologies 
Rimadyl (Carprofen) Zoetis 
Trypan Blue Solution, 0.4% Sigma-Aldrich 
Trypsin-EDTA, phenol red, 0.25% Thermo Fisher Scientific 
Xylazine WDT 
2.1.2 Kits 
Description Manufacturer 
Agilent RNA 6000 Nano Chip Kit  Agilent Technologies 
Colorimetric Cell Viability Kit III (XTT) Promocell 
GeneChip® Hybridization, Wash and Stain Kit Thermo Fisher Scientific 
GeneChip® WT Plus Reagent Kit Thermo Fisher Scientific 
Rat C-Reactive Protein ELISA Kit (PTX1) Abcam 
RNase-Free DNase Set Qiagen 
RNeasy Fibrous Tissue Mini Kit Qiagen 
2.1.3 Equipment 
Description Manufacturer 
12-Well plates, black, glass bottom In vitro Scientific 
AcuPunch Skin Biopsy Punches, 6mm Acuderm 
ACCU-CHEK® Compact Glucose (Test Strip) Roche Diagnostics 
Cell Culture Flasks, different sizes Greiner Bio-One International 
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Cell Culture Multiwell Plate 12-well, transparent Greiner Bio-One International 
Corning® Costar® 6-Well Plates, transparent Sigma-Aldrich 
Corning® Costar® 96-Well Plates, black, clear 
bottom 
Sigma-Aldrich 
Elastic net bandage, 3.5 cm width MaiMed Medical 
GeneChip® Rat Genome 230 2.0 Microarrays Affymetrix 
Leukosilk® BSN Medical 
LUNA™ Cell Counting Slides Logos Biosystems 
NanoQuant Plate™ Tecan Group 
NG4 grey glass filter after Schott, 10%, D1.0 ITOS 
PMI 5008 mod. rat feed ssniff Spezialdiäten 
Prototype Pocket M4000 Laboratoires URGO S.A. 
Skin  polymer model Laboratoires URGO S.A. 
ThinCert™, 0.4 µm, transparent Greiner Bio-One International 
UrgoStart Wound Dressing E2723 Laboratoires URGO S.A. 
2.1.4 Devices 
Description Manufacturer 
818-ST2-UV/DB Metal Wand Photodetector Newport Corporation 
ACCU-CHEK® Compact Plus Glucometer Roche Diabetes Care 
Agilent 2100 Bioanalyzer Agilent Technologies 
Automatic Tissue Processor TP1020 Leica Biosystems 
Axio Scan.Z1 Microscope Carl Zeiss 
BioLight LED lamp Philips Research 
Cobas c 311 Analyzer Roche Diagnostics 
Digital Multimeter DMM230 Multmetrix® 
DNA Engine® Peltier Thermal Cycler Bio-Rad 
Economical Handheld Laser Power & Energy 
Meter, 843-R-USB  
Newport Corporation 
Eppendorf® Microcentrifuge 5415 L Eppendorf 
GeneChip® Cartridge Array Affymetrix 
GeneChip® Hybridisation Oven 640 Affymetrix 
GeneChip® Fluidics Station 450 Affymetrix 
GeneChip® Scanner 3000 Affymetrix 
HERAcell™ VIOS 160i Incubator Thermo Fisher Scientific 
Heraeus® Biofuge, primo R Thermo Fisher Scientific 
HERAsafe™ Laminar Flow Cabinet Thermo Fisher Scientific 
IncuCyte® ZOOM System Essen Bioscience 
Infinite® M200 PRO Microplate Reader Tecan Group 
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Inverted Microscope DM IRB Leica Microsystems 
LUNA™ Automated Cell Counter Logos Biosystems 
Microscope DM IRBE Leica Microsystems 
MEDILIGHT prototype MEDILIGHT 
Spark® 10M Multimode Microplate Reader Tecan Group 
ST5010 Autostainer XL Leica Biosystems 
Thermocouple Type K RS PRO 
ThermoStat Plus Eppendorf 
TissueLyser II Qiagen 
USB TC-08 Thermocouple Data Logger Pico Technology 
2.1.5 Software 
Description Manufacturer/Application 
AutoScratchSeg (MATLAB) 
MATLAB based GUI program to determine 
wound areas of scratch assay 
AutoWoundSeg (MATLAB) 
MATLAB based GUI program to determine 
wound areas of animals 
Bio-formats (Fiji function) 
Open source software to import images from 
Axio Scan microscope from Zeiss 
Countpix Macro Fiji macro to process segmented ilastik images 
Fiji 
Open source software for image analysis based 
on ImageJ 
Ilastik 
Open source software for interactive image 
classification, segmentation and analysis based 
on Python 
IncuCyte® S3 Acquisition interface Essen BioScience 
JMP Genomics version 7.1 SAS Institute Inc. 
Leica Application Suite X (LAS X) Leica Biosystems 
MEDILIGHT App V2.5 MEDILIGHT 
PicoLog 6 data logging software Pico Technology 
PMManager Application Software Newport Corporation 
ZEN 2 (blue edition) Axio Scan software Carl Zeiss 
 Light sources and their characteristics 2.2
For the various in vitro and in vivo experiments, different light sources were used. 
The properties of their set-up and the characteristics of the LEDs used are listed in 
Table 1 for each type of lamp. 
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Table 1: Properties of different light sources used in the experiments. 
 Philips BioLight ENMECH board 
MEDILIGHT 
Prototype 
Distance to Surface [cm] 5 5 0 
Number of LEDs 128 84 32 
Irradiance [mW/cm²] 23 23 23 
Peak Wavelength [nm] 453 455 453 
Irradiation field [cm²] 150 316 16 
 
The lamp provided by Philips Research (Eindhoven, Netherlands) was used for the 
initial in vitro experiments. The light source consists of LUXEON Rebel LXML-PR01-
0275 (blue) LEDs from Lumileds (Amsterdam, Netherlands). 12- and 96-well plates 
were irradiated at a distance of 5 cm in this set-up, as shown in Figure 3.  
 
Figure 3: Irradiation set-up for in vitro studies with the Philips BioLight. 
For in vivo short-term and the first long-term irradiation experiments a rigid board was 
used that was built by ENMECH (Berlin, Germany). For the LEDs the LUXEON Z 
Royal Blue LXZ1-PR01 from Lumileds were used. The peak wavelength is between 
450 and 455 nm and the lamp was used, as well as the Philips lamp, at an irradiance 
of 23 mW/cm². Between the lamp and the animal a diffusion plate was placed to 
increase homogeneity of the irradiation field (Figure 4). 
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Figure 4: Irradiation set-up for in vivo studies with the ENMECH board. 
In vitro as well as in vivo experiments were performed with the MEDILIGHT 
prototype. In contrast to the previous two light sources (Philips and ENMECH) there 
was no distance between the plate/animal and the LEDs. Irradiance was always set 
to 23 mW/cm² adjustable by the duty cycle in the MEDILIGHT software. The 
MEDILIGHT prototype consists of two parts: the encapsulated, electronic module and 
the flexible LED foil (Figure 5). In the electronic module the battery and the control 
unit for the LEDs and sensors are integrated, as well as a data transmitter. It is 
encapsulated in a plastic housing and can be attached to a diabetic pressure relief 
shoe with a plastic clip. Throughout the experiments, the prototype was developed 
and components added. One of these components is a white back reflector that is 
attached to the LED foil to reflect scattered light. Also, the flexible foil was 
encapsulated with silicone to prevent pressure marks from the integrated parts. 
Additionally the silicone encapsulation makes it possible to disinfect the device. 
During optimization the battery capacity and the range of irradiance was increased. 
Also the connection between the flexible foil and the electronic module was made 
more stable and the encapsulation of the electronic module was redesigned to be 
water-resistant.   
 
Figure 5: MEDILIGHT Prototype consisting of the electronic module and silicone encapsulated flex foil. 
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On top of that two different types of sensors were placed on the LED foil (Figure 6). 
First, there are five temperature sensors, of which one is placed in the center and the 
other four on each corner of the flexible foil. These sensors can measure the patient’s 
or the animal’s skin temperature, as well as monitor the temperature of the LEDs.  
Second, there are four pulse oximetry sensors, consisting of red and infrared LEDs, 
respectively, as well as a photodiode. They are used to monitor and map changes in 
blood oxygenation levels, but are not relevant for this study. 
 
Figure 6: Schematic display of MEDILIGHT flex foil with respective sensors for temperature and pulse 
oximetry. Image was taken from MEDILIGHT deliverable created by K. Michaelides
84
. 
The device is controlled by a phone App that is connected by Bluetooth. Different 
irradiation modes can be used. It is possible to adjust the maximum and minimum 
temperature for the central sensor, by LEDs turning on and off accordingly. Another 
possibility to regulate the irradiation time is to adjust the total irradiation time, the total 
break time, or the irradiation and break time independently from one another.  
 Development of an in vitro skin model and assessing the effects of blue light 2.3
2.3.1 Cell lines 
For in vitro experiments two different cell lines were used (Table 2).  
Table 2: Cell lines used to test effects of blue light in vitro. 
Cell line Species Tissue Medium Company 
HaCaT (immortal human keratinocytes) Human Skin DMEM CLS 
NHDF (normal human dermal fibroblasts) Human Skin DMEM PromoCell 
One was an immortal human keratinocyte cell line, HaCaT, which is a permanent cell 
line (spontaneously immortalized aneuploid human keratinocyte cell line). 
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Additionally, normal human dermal fibroblasts (NHDF) from an adult donor were used 
in the form of a primary cell line. 
2.3.2 Culturing cells 
For culturing HaCaT cells Dulbecco’s modified Eagles medium with high glucose 
(DMEM GlutaMAX™) was used. Supplements were 10% fetal bovine serum (FBS), 
1  mM sodium pyruvate and 100 U/mL penicillin/streptomycin (pen/strep) (Gibco® by 
Life Technologies (Carlsbad, CA, USA)). Standard conditions for culturing the cells 
were 37°C and a CO2 concentration of 5%. For passaging 0.25% trypsin/EDTA from 
Gibco® was used as a dilution with phosphate buffered saline (PBS), producing a 
final concentration of 0.1%. Cells were incubated for 10 min under standard 
conditions to detach the cells. 1:20 dilutions were produced for long-term cultivation 
(2 weeks) and lower dilutions for use after 3 days (1:4 or 1:3). Volumes for different 
flask sizes of the solutions are listed in Table 3. For the NHDF cells DMEM 
GlutaMAX™ was used as base medium as well. Supplements were 100 U/mL 
pen/strep and SupplementMix Fibroblast Growth Medium 3 (with FBS) from 
PromoCell (Heidelberg, Germany) and 5 mL sodium pyruvate. Standard conditions 
for culturing were identical to the keratinocyte conditions. For passaging cells were 
treated with 0.25% trypsin/EDTA in a 1:16 dilution with PBS (final concentration of 
0.04%). The cells were incubated for 3 min under standard conditions. 1:20 dilutions 
were made for long-term cultivation (2 weeks) and lower dilutions for use after 3 days 
(1:4 or 1:3). The cells were used up to passage 15. Volumes for different flask sizes 
of the used solutions are listed in Table 3 and are the same as for HaCaT cells. 
Co-culture medium consisted of DMEM GlutaMAX™, 100 U/mL pen/strep, 
SupplementMix Fibroblast Growth Medium (without FBS) and 5 mL sodium pyruvate. 
Table 3: Volumes of solutions for keratinocytes and fibroblasts, cultivated in different flask sizes (Txxx). 
The numbers of the flasks refer to the cultivation area in cm². 
 
T175 
[mL] 
T75 
[mL] 
T25 
[mL] 
96-well plate 
[mL] 
Medium 25.0 15.0 5.0 0.100 
PBS 5.0 3.0 2.0 0.050 
Trypsin/EDTA (diluted in PBS) 5.0 3.0 2.0 0.050 
Medium (stopping) 5.0 3.0 2.0 - 
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2.3.3 Co-culturing 
In Figure 7 a schematic drawing is shown on how the fibroblasts were cultivated on 
the underside of the membrane. The cell culture insert from Greiner Bio-One 
International (Frickenhausen, Germany) ‘ThinCert™’ is positioned in a well and both 
insert and well are filled with medium, so that the fibroblasts are prevented from 
entering the inner part of the insert.  
 
Figure 7: Cultivation model with cell culture insert ‘ThinCert™’ placed in a well with fibroblasts growing 
on the underside of the membrane. The well and the insert are both filled with medium 
85
. 
In Figure 8 the co-culture model is presented. The keratinocytes are located on top of 
the membrane where they can communicate via signal peptides, but cannot mix with 
fibroblasts. 
 
Figure 8: Co-cultivation model with cell culture insert ‘ThinCert™’ placed in a well with fibroblasts 
growing on the underside of the insert and keratinocytes growing inside of the insert. Together they form 
an interactive cell layer 
85
. 
To gain this interactive cell layer 12-well ThinCerts™ with a transparent membrane 
(2×106 cm-1 pore density) and 0.4 µm pore size were inverted and placed into a 
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6-well plate (Figure 9/A). To create a humid environment 340 µL sterile water were 
pipetted to the bottom of the well (Figure 9/B). 200 µL of NHDF cell suspension 
containing 36,000 cells in fibroblast medium were pipetted onto the underside of the 
membrane (Figure 9/C+D). 
 
Figure 9: Procedure of preparing co-cultures with ThinCerts™ step by step 
85
. 
The plate was covered with a lid, holding the cell suspension to the membrane 
(Figure 9/E). The cells were allowed to adhere overnight under standard conditions. 
Afterwards, the inserts were placed into a 12-well plate, pre-filled with 1.5 mL co-
culture medium (described in 2.3.2) (Figure 9/F). 600 µL of HaCaT cell suspension 
containing 96,000 cells in co-culture medium were added into the insert well and 
cultivated overnight. On the next day experiments were started. 
2.3.4 Harvesting of co-cultures for XTT assay in 96-well plates 
To harvest the cells, the medium was removed from the bottom well, as well as from 
inside the ThinCerts™. The inserts and the well bottom were rinsed once with 2.0 mL 
PBS in total. 1.5 mL of 0.04% Trypsin/EDTA was added to the well bottom and 
incubated for 5 min at standard conditions. Meanwhile the PBS was left inside the 
insert to protect the keratinocytes from dehydration. Falcon tubes were pre-filled with 
5 mL fibroblast medium and the fibroblast cell suspension was added after the 
incubation time. Then 0.3 mL 0.1% Trypsin/EDTA was pipetted into the insert and 
incubated for 5 min at standard conditions and the keratinocyte cell suspension 
collected in a Falcon tube prefilled with 5 mL keratinocyte medium. The tubes were 
vortexed to re-suspend the cells and centrifuged for 3 min at 220×g. The medium 
was removed from the centrifuge tube, leaving the cell pellet, which was re-
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suspended in an appropriate amount of medium 85. The cell suspension was divided 
into 96-well plates (100 µL per well) and incubated for 30 min at standard conditions 
with a subsequent XTT test. 
2.3.5 Irradiation with blue light of mono-cultures and mixed cultures in 96-well plates 
To study the effect of light irradiation on cells, cells were seeded in black 96-well 
plates with a clear flat bottom surface. For mono-cultures, HaCaT cells were seeded 
at a concentration of 10,000 cells/well and NHDF cells with 7,500 cells/well. In mixed 
cultures both cell types were seeded at a concentration of 5,000 cells/well 
respectively. The plates were incubated for 24 h at standard conditions and blue light 
irradiation with different irradiances followed. 24 h after irradiation XTT test was 
performed. 
In prototype studies, the set-up was changed regarding the distance of the light 
source. While for the first experiments the Philips BioLight was used at a distance of 
5 cm, the MEDILIGHT prototype was placed directly on top of the cell culture plate. 
Different configurations were tested where components were added to the set-up. 
Experiments with a spacer, diffusor and a wound dressing were performed to 
possibly increase the homogeneity of the illumination area, by simply placing one or 
more components between the cell culture plate and the LED foil.  
2.3.6 Colorimetric cell viability (XTT) assay 
To test possible changes of metabolic activity the Colorimetric Cell Viability Kit III 
from PromoKine was used. 50 µL of labeling-mixture containing labeling reagent and 
electron coupling reagent were added to the cell suspension and incubated for 1 h. 
Here the tetrazolium salt XTT is metabolized to water soluble formazan dye. Only 
viable cells have the ability to metabolize the salt, hence this kit is used to directly 
quantify the metabolic activity. The orange formazan is measured by 
spectrophotometric absorption at 450 nm (690 nm as reference wavelength) with 
Infinite® 200 PRO microplate reader from Tecan. Results of irradiated samples are 
normalized to the control, which were located on the same plate. Experiments were 
done in triplicates and repeated three times. 
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2.3.7 Scratch wound healing assay 
First, cells (keratinocytes, fibroblasts or mixed culture) were seeded in 12-well plates 
with the cell numbers depicted in Table 4.  
Table 4: Number of cells for different types of scratch tests. 
Culture 
Number of 
Keratinocytes 
per Well 
Number of 
Fibroblasts per 
Well 
Total cell 
number 
per Well 
Cultivation time 
[h] 
Keratinocytes 300,000 0 300,000 24 
Fibroblasts 0 60,000 60,000 48 
Mixed culture 45,000 45,000 90,000 48 
 
 
 
Figure 10: Work-flow of scratch wound healing 
assay 
86, 87
. 
To test the migration and proliferation of 
cells, a scratch assay was performed. 
The workflow is shown in Figure 10. The 
respective cells were grown to 
confluence within 24 to 48 h. With a 
scratch device an artificial wound was 
created in the middle of the plate (see 
Figure 11) by removing cells in a defined 
area, causing gaps of the same size. By 
creating the artificial wound, cells were 
detached from the well surface; therefore 
a washing step with PBS followed and 
the wells were refilled with medium. At 
time point 0 h images of the gaps were 
taken directly after the procedure with an 
inverted microscope, followed by light 
treatment. Image acquisition took place 
in regular time intervals until the gap was 
closed completely. 
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Figure 11: Scratch device used in 12-well plates to create an artificial wound. 
Images were evaluated with the AutoScratchSeg program (Fiji plugin), where the 
area of the gap was determined in pixels (Figure 12) and further converted to % of 
the initial wound area at 0 h.  
 
Figure 12: Exemplary evaluation of scratch wounds with the evaluation software AutoScratchSeg (based 
on MATLAB). 
Two images per well were taken, generating 24 images per plate. Experiments were 
performed in triplicates with three repetitions.  
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 In vivo studies to test the effects of blue light on rats 2.4
2.4.1 Animal groups 
All experiments were conducted in accordance with the German Animal Protection 
Law and approved by the Regierungspräsidium Karlsruhe (in agreement with EU 
Guideline 2010/63/EU) with the permission number G-183/16. 
To investigate short-term effects of blue light irradiation (section 2.4.2.1), 24 male 
ZDF fa/+ (lean) rats (Charles River Laboratories, Wilmington, MA, USA) at the age of 
12 weeks, were used. All groups of rats are summarized in Table 5.  
For both long-term experiments (section 2.4.2.2 for irradiation with ENMECH board 
and 2.4.2.3 for irradiation with the MEDILIGHT prototype) 12 male ZDF fa/fa (obese) 
rats (ZDF-Leprfa) were ordered, respectively, at the age of 6 weeks. Additional 6 male 
ZDF fa/+ (lean) rats (ZDF-Leprfa/Crl) were used in the first long-term experiment to 
compare the effect between the diabetic and non-diabetic wound model. 
Table 5: Groups of rats used in the distinct experiments with their respective conditions and numbers. 
Experiment Rat Strain Condition 
Number of 
Animals 
Animals per 
Experiment 
Short-term 
irradiation 
ZDF fa/+ (lean) 
00.00 J/cm² 6 
Σ = 24 
10.35 J/cm² 6 
41.40 J/cm² 6 
82.80 J/cm² 6 
Long-term 
irradiation 
(ENMECH board) 
ZDF fa/fa 
(obese) 
Control 6 
Σ = 18 Irradiated 6 
ZDF fa/fa (lean) Irradiated 6 
Long-term 
irradiation 
(MEDILIGHT 
prototype) 
ZDF fa/fa 
(obese) 
Control 6 
Σ = 12 
Irradiated 6 
 
All rats were fed a special diet for 6 weeks, consisting of PMI 5008 mod. (ssniff 
Spezialdiäten, Soest, Germany). With 18 kJ% fat, 27 kJ% protein and 55 kJ% 
carbohydrates, this feed (Figure 13) is different from the standard, containing more 
fat and protein and therefore less carbohydrates (standard feed: 9 kJ% fat, 24 kJ%,  
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Figure 13: Energy content and distribution of 
ingredients 
88
. 
67 kJ%). This led consistently to the 
development of Type 2 diabetes in the 
ZDF fa/fa strain, as they are 
homozygous for the leptin receptor 
gene deficiency. Before the start of 
the experiments all rats were housed 
in sets of two and three until reaching 
the age of 12 weeks, when they were 
separated and kept in individual 
cages. Food and water was provided 
ad libitum. The rats were exposed to a 
12-hour light/dark cycle.   
2.4.2 Study design for testing the effects of blue light on diabetic and non-diabetic 
rats 
From in vitro studies different doses of blue light were identified for different treatment 
purposes. One of these is using a fluence of 10.35 J/cm² to achieve a proliferative 
effect, enhancing the epidermisation of a wound and faster wound closure. Further, 
41.40 J/cm² were tested to induce an anti-proliferative effect, preventing premature 
wound closure. In addition, 82.80 J/cm² of blue light were tested. This fluence was 
found to not only induce anti-proliferative effects, but also to lead to anti-bacterial 
effects (separate project and experimenter). First, the doses had to be tested 
individually, leading to the design of short-term experiments. As no adverse effects 
were found, the whole light schedule, with all individual treatments included, was 
tested in a long-term study. To be able to apply the wound healing therapy in 
patients, the newly developed MEDILIGHT prototype was tested for its efficacy in a 
separate long-term study. 
2.4.2.1 Short-term blue light irradiation of non-diabetic rats 
To compare the short-term effects of blue light after a single irradiation with different 
doses of blue light, non-diabetic ZDF fa/+ rats were used. The rats were ordered at 
the age of around 8 weeks (no older rats were available) and housed until reaching 
the age of 12 weeks.  Then, the experiment was started (Figure 14). Blood glucose 
measurements (see section 2.4.3) were performed weekly as well as monitoring of 
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body weight, until rats reached the desired age. Part of the back of the rats was 
depilated with an electric shaver for small rodents under short isoflurane anaesthesia 
to prepare it for application of the biopsy punch. As their skin was irritated from the 
shaving, all experiments were started on the next day.  
 
Figure 14: Experimental schedule for short-term irradiation with the ENMECH board. 
Here, blood sampling took place under isoflurane anaesthesia and around 500 µL of 
blood were extracted from the retro-orbital venous plexus (section 2.4.4). While still 
under isoflurane anaesthesia, ketamine/xylazine was injected by intraperitoneal 
administration. The rats were relocated back into their cages for a quiet and dark 
environment. As soon as anaesthesia set in the skin surface was disinfected and two 
discs of skin were removed (Figure 15).  
 
Figure 15: Two wounds created by a biopsy punch with a diameter of 6mm at a distance of 3 cm. 
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To create the wounds AcuPunch Skin biopsy punches from Acuderm were used with 
a size of 6 mm. Skin disks were extracted at a distance of 3 cm and consisted of full 
thickness skin while not causing any injury of the fascia. Images were taken with two 
rulers (x- and y-axis), to be able to later evaluate the area of the wounds with Fiji (see 
section 2.4.5). 
Following 30 min waiting time, rats were irradiated either for 7.5 min (10.35 J/cm²), 
30 min (41.40 J/cm²) or 60 min (82.80 J/cm²), excluding the control rats. In this set-
up, the ENMECH board was used at a power density of 23 mW/cm² and a distance of 
5 cm. Control rats were placed on a heating mat to simulate the heat development 
under the lamp, to keep the conditions as equal as possible. For better air circulation, 
rats were irradiated in a steel cage (Figure 16).  
  
Figure 16: Irradiation of rats in a steel cage with rigid ENMECH board placed on top. One of the wounds is 
covered with a lightproof foil. 
To test possible systemic effects one of the wounds was covered with aluminum foil 
during irradiation. To avoid falsifying the data due to anti-bacterial properties of the 
aluminum foil, the foil itself was covered with Leukosilk, in case it got into contact with 
the wound. A thermometer was placed under the rat to keep track of the temperature. 
The heating pad was turned on in case the rat was cooling out as a result of the 
anaesthesia. 
After irradiation 1.5 mL of 0.9% NaCl-solution were injected subcutaneously to 
compense for dehydration during anaesthesia. Also an analgesic (Carprofen 
5 mg/kg BW) was administered subcutaneously to reduce pain. Carprofen was 
applied after irradiation due to phototoxicity of the pharmaceutical. After becoming 
conscious, indicated by first directed movements, wound dressings from URGO RID 
were applied. A flexible bandage (MaiMed Medical) was added on top of the wound 
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dressings to keep them in place (Figure 17). 24 h post irradiation blood sampling was 
performed under isoflurane and images of the wounds were taken again. 
 
Figure 17: Rat with wound dressing from URGO RID and flexible bandage. 
For organ collection, rats were deeply anaesthetized with ketamine/xylazin 
(100 mg/kg, 5 mg/kg) and samples for RNA isolation (for gene expression analyses) 
were extracted (section 2.4.6). Thereafter the rat was perfused (section 2.4.8).  
2.4.2.2 Long-term blue light irradiation of diabetic and non-diabetic rats 
For long-term irradiation 12 ZDF fa/fa (obese) and 6 ZDF fa/+ (lean) rats were 
ordered at the age of 6 weeks. All of the rats were fed a special diet (PMI 5008 
mod.), a diet high in proteins and fat. While the lean strain of these rats did not show 
any effects from this diet, the obese strain developed Type 2 diabetes.  
This could be tracked during the induction phase of 6 weeks by increased blood 
glucose levels, which were measured once to twice a week (section 2.4.3). As soon 
as the rats had reached the age of 12 weeks, the experiment was started (to be 
comparable to the previous study: 2.4.2.1 Short-term blue light irradiation of non-
diabetic rats). The workflow followed the experimental schedule shown in Figure 18. 
One day before applying the wounds, another blood glucose measurement was 
performed and the backs of the rats were depilated. One day later, blood sampling 
took place. Ketamine/xylazine anaesthesia was applied intraperitoneally and the 
wounds were created with a biopsy punch. Images were taken after waiting for 
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30 min, followed by an irradiation with 82.80 J/cm² of blue light at a power density of 
23 mW/cm² with the ENMECH board. On day two and three, irradiations with the 
same dose took place under MMF anaesthesia (Midazolam 0.5 mg/kg, Medetomidine 
0.0375 mg/kg, Fentanyl 0.00125 mg/kg). The following three days an irradiation with 
41.40 J/cm² of blue light was applied, followed by three days of irradiating with 
10.35 J/cm². The last three days only every second day blue light was applied, 
meaning only on day 11 irradiation took place. With decreasing doses of blue light, 
and therefore irradiation times, the concentration of MMF anaesthesia was reduced 
accordingly (half of dose for 41.40 J/cm², quarter of dose for 10.35 J/cm²) for control 
and irradiated rats equally. Before every irradiation images of the wounds were 
taken. After irradiation treatment remained as in the previous experiment, meaning 
Carprofen was applied for a total of 3 days and NaCl solution was injected after each 
irradiation.  
 
Figure 18: Experimental schedule for long-term irradiation with the ENMECH board. 
24 h after the last irradiation retro-orbital blood sampling took place under isoflurane 
and images of the wounds were taken again. For organ collection rats were deeply 
anesthetized with ketamine/xylazin and samples for RNA isolation (for gene 
expression analyses) extracted. Thereafter the rat was perfused (section 2.4.8).  
2.4.2.3 Long-term blue light irradiation of diabetic and non-diabetic rats with the 
MEDILIGHT prototype 
For long-term irradiation with the MEDILIGHT prototype the same experimental 
design was chosen as for the long-term irradiation with the rigid board from ENMECH 
(Figure 19). Also 12 diabetic rats were used in this experiment, of which 6 animals 
were assigned to the irradiated group and 6 animals served as the control group. 
They were irradiated during 12 consecutive days, where only the epidermisation 
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phase was tested. Hence, irradiation took place only every second day with 
10.35 J/cm² of blue light under MMF anaesthesia. Another blood sampling was 
added in the middle of the experiment, to analyze possible differences immediately 
after irradiation. 
 
Figure 19: Experimental schedule for long-term irradiation with the MEDILIGHT prototype. 
For irradiation the MEDILIGHT prototype was used at a duty cycle of 42%. To meet 
the requirements of the final product it was irradiated through the wound 
dressing (Figure 20). 
 
Figure 20: Experimental set-up for blue light irradiation of rats with the MEDILIGHT prototype through the 
wound dressing. One of the wounds was covered with aluminum foil to test a possible systemic effect. 
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As the irradiation time was only 7.5 min, concentration of MMF was reduced 
accordingly. Other sampling procedures remained as described in 2.4.2.1, with 
retrograde perfusion on the last day. 
2.4.3 Blood glucose measurement 
For blood glucose measurement, the tails of animals were punctured with a needle. A 
drop of blood was measured with the glucose test strips and the ACCU-CHEK® 
Compact Plus blood glucose meter from Roche Diagnostics. The bleeding was 
stopped by applying pressure with a tissue and the glucose concentrations were 
noted down. 
High glucose concentrations (over 600 mg/dL) were a criterion to exclude animals 
from the study. If consistently high values occurred, animals were sacrificed before 
the start of the experiment.  
2.4.4 Blood sampling from the retro-orbital venous plexus, plasma separation and 
analysis of plasma 
Blood samples were taken with a glass capillary from the retro-orbital venous plexus. 
The blood was collected in lithium-heparinized reaction tubes (Sarstedt, Nümbrecht, 
Germany). Directly after sampling, the blood was distributed evenly in the tube by 
inverting it. The samples were cooled on ice immediately and centrifuged at 500 rpm 
for 5 min. By centrifugation the plasma was separated from the erythrocytes. The 
plasma was placed into a fresh tube while the remains were discarded. Samples 
were frozen at -80°C until further processing either with the Cobas c 311 analyzer 
from Roche or in an ELISA kit for C-reactive protein (CRP) from Abcam.  
 
With the Cobas analyzer a full plasma profile (cholesterol, protein, triglycerides) was 
tested including kidney (urea, creatinine, sodium, potassium, calcium, phosphate) 
and liver function profiles (Alanine Aminotransferase (ALT), Aspartate 
Aminotransferase (AST), Glutamate Dehydrogenase (GLDH)). 
 
To test for CRP plasma samples had to be diluted 1:60.000 and the experiment was 
performed according to the manufacturer’s instruction. Triple determination was 
performed for each sample. 
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2.4.5 Wound area evaluation with Fiji 
Images of wounds were taken every day to be able to compare wound areas 
between the different groups of an experiment. Images were evaluated with the 
freehand selection of Fiji, which is an open source image processing package based 
on ImageJ. With this tool the pixel size could be associated with the rulers, thus 
allowing to convert the wound area to mm2 (Figure 21). 
 
Figure 21: Image processing with Fiji software using the freehand tool to measure wound areas. 
2.4.6 Homogenization and RNA extraction from tissue samples 
Tissue samples for RNA extraction were taken from both sides of the skin (control 
and irradiated), including tissue from the wound site. Samples were cut into cubes 
measuring 1 mm³, snap frozen in liquid nitrogen and stored at -80°C. One of the pre-
cut cubes was taken at a time to be homogenized in the Qiagen TissueLyser II. A 
reaction tube was filled with RLT lysis buffer from RNeasy fibrous tissue mini kit from 
Qiagen and a steel bead. The reaction tubes were transferred to the Qiagen 
TissueLyser II and shaken at 30 Hz for 3 min to disrupt the tissue. Every 30 s the 
reaction tubes were cooled down on ice preventing degradation of RNA. Afterwards 
RNA was isolated from the homogenized tissue with the RNeasy fibrous tissue mini 
kit, following the manufacturer’s instructions.  
For that the homogenized tissue was incubated with protease K for 10 min at 55°C. 
Then, the RNA was separated from cell debris, DNA and protein by 3 min 
centrifugation at 10000xg. The upper aqueous phase was transferred into a fresh 
reaction tube. Adding ethanol to the aqueous phase, it was centrifuged through the 
spin column, where the RNA bound to a silica-membrane. Genomic DNA was 
digested with DNase and the membrane washed with RW1 and RPE buffer. Finally 
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RNA was eluted with RNase-free water from the membrane. In the end the RNA 
concentration was determined spectrophotometrically by using an Infinite® 200 PRO 
microplate reader from Tecan Group AG (Männedorf, Switzerland). Here, the 
A260/A280 ratio was measured and acceptable ratios for samples to be included in 
experiments were 1.9 to 2.1. Samples were further analyzed by testing the RNA 
integrity using an Agilent 2100 Bioanalyzer and RNA 6000 Nano Chip. 
2.4.7 Gene expression analysis with Affymetrix GeneChips 
From 100 ng of isolated RNA, biotinylated antisense cDNA was obtained by using the 
GeneChip® WT Plus Reagent Kit and the GeneChip® Hybridization, Wash and Stain 
Kit from Thermo Fisher Scientific. Then, cDNA was fragmented and labeled to be 
hybridized onto GeneChip® Rat Genome 230 2.0 microarrays with an incubation 
time of 16 h at 45°C. For gene expression profiling, chips were dyed in a GeneChip® 
Fluidics station 450 and scanned with a GeneChip® Scanner 3000, both obtained 
from Affymetrix.  
Custom CDF version 18 with ENTREZ based gene definitions was used for 
annotation. Applying quantile normalization and RMA background correction, the raw 
fluorescence intensity values were normalized. Based on OneWay-ANOVA, 
differential gene expression was analyzed using a commercial software package: 
JMP Genomics, version 7, from SAS Institute. A false positive rate of a = 0.05 with 
FDR correction was defined as the level of significance. 
Gene set enrichment analysis (GSEA) was performed to determine whether defined 
lists (or sets) of genes exhibit a statistically significant bias in their distribution within a 
ranked gene list (see http://www.broadinstitute.org/gsea). Pathways belonging to 
various cell functions were obtained from the public database KEGG. 
2.4.8 Retrograde Body Perfusion 
As preparation for the retrograde perfusion heparinized saline and 4% PFA were 
prepared and pH adjusted to 7.4. The solutions were filled into perfusion bottles and 
the tubes were connected to a compressor. Then, the compressor was started and 
the pressure adjusted to 280 mbar. 
The abdomen of the animal was opened. The organs were pushed aside with a swab 
and the aorta and vena cava were located and dissected from surrounding tissue. A 
butterfly needle, connected to the perfusion bottles, was inserted into the aorta near 
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the kidney vessels and clamped. The vena cava then was cut. The animal was 
flushed with heparinized saline for 3 min followed by flushing with 4% PFA for 
additional 3 min. Finally organs were collected.  
2.4.9 Sample collection and processing for evaluation of histology 
Organs that were removed from the perfused animals were cut into axial slices with a 
thickness of around 5 mm. After fixation in 4% PFA for 24 h, they were stored in 
diluted 2% PFA. Then, they were dehydrated in the automatic tissue processor 
TP1020 Leica Biosystems and embedded in paraffin. From these paraffin blocks 
slices with a thickness of 3 µm were cut with a semi-automated rotary microtome 
from Leica Biosystems. After fixation in a heat chamber for 1 h at 60°C they were 
stained with hematoxylin and eosin (H&E) in the Leica Biosystems Autostainer XL. 
Finally, they were covered with Eukitt and sealed with a cover slip. 
The histology slides were imaged with the Axio Scan.Z1 microscope from Carl Zeiss 
using a 40x objective. To analyze morphological structures, images were exported 
from the ZEN software (Carl Zeiss) and segmented into different classes 
(inflammatory site, fibrin, leukocytes, and epidermis) with the ilastik software. The 
segmented images were quantified by pixels in ImageJ with the Countpix macro. The 
areas of the classes were determined in pixels and transferred to mm² through the 
resolution of the image.  
 EU project MEDILIGHT: prototype temperature testing on a skin polymer mode 2.5
and pigs 
During development of the MEDILIGHT prototype, 5 temperature sensors (one in the 
center, 4 on each corner) were integrated into the flexible LED foil. They were added 
to track the heat build-up caused by the LEDs as a safety measure to later avoid 
burns on the patient’s skin. The efficacy of these sensors had to be tested and 
verified. As initial experiments, the sensors were tested on a skin model consisting of 
a dyed gelatin polymer provided by Laboratoires URGO S.A. To imitate the human 
body temperature, the polymer was placed on a ThermoStat Plus heat block from 
Eppendorf and was heated to 35°C. As reference, two external sensors were placed 
on top of the polymer, one sensor in the center and one on the rim. To be in line with 
the final set-up, the wound dressing E2723 from URGO, followed by the flexible LED 
foil and the pocket, were added. While the prototypes were changing (flexible LED 
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foil, back reflector, silicone encapsulation, wound dressing, pocket), the set-up 
remained the same (compare Figure 22). 
  
Figure 22: Experimental set-up for temperature measurements on skin polymer model with MEDILIGHT 
prototypes. 
The temperature was tracked over 1 hour by the sensors placed on the prototype as 
well as by the external sensors, while the LEDs of the MEDILIGHT prototype were 
switched on.  
For the prototype the MEDILIGHT App V2.5 for Android was used on a Samsung 
Galaxy J3 DUOS smartphone to track and store the data via Bluetooth. The external 
temperature sensors were driven by Thermocouple Data Logger USB TC-08 from 
Pico Technology and the data transmitted via USB to a computer. To track and save 
the data the PicoLog 6 data logging software from Pico Technology was used.  
While the MEDILIGHT prototype was developed, the software was updated 
continuously. New features were integrated into the software such as the possibility 
to regulate irradiation cycles with breaks in between. Also on/off times of the LEDs in 
relation to a definable minimum or maximum temperature could be adjusted. With 
these safety measures it was possible to define a maximum temperature where the 
LEDs of the flexible foil were turned off automatically. This gave the opportunity to 
test the efficacy of the MEDILIGHT prototype on the skin of Aachen minipigs with the 
permission number G-78/18. Male Aachen minipigs (Heinrichs Tierzucht, Heinsberg, 
Germany) were used, weighting around 25 kg. The experimental set-up on the flank 
of the pig is displayed in Figure 23.  
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Figure 23: Set-up for experiments on pigs with four MEDILIGHT prototypes. The external sensor was placed 
directly on the skin surface, partially with the wound dressing E2723 included. 
Four external sensors were placed directly in contact with the skin, to track the 
surface temperature (Figure 23 A). Two of these prototypes were placed on the 
wound dressing E2723 to test the differences for each condition on the heat-build up. 
When involving the wound dressing in the experiments, the irradiance, and therefore 
the duty cycle, of the prototype had to be increased to make up for the loss of power 
by the additional layer. This led to a higher power input which subsequently could 
result in an increased build-up of heat.  
The MEDILIGHT prototypes were fixed with the pockets (Laboratoires URGO) on top 
of the wound dressings and external sensors (Figure 23 B). Two of the four 
prototypes were used to track the heat build-up, one with the wound dressing and 
one without, respectively, during irradiation. Both of these prototypes were adjusted 
to have an irradiance of 23 mW/cm² on the surface of the skin. They were run not 
only run in continuous but also in cycled mode, turning off at a maximum temperature 
of 40°C and turning on at a minimum temperature of 37°C. The other two prototypes 
tracked the temperature to obtain a reference measurement.  
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The experiment was carried out for a period of 1 hour. Data from the 5 sensors of the 
MEDILIGHT prototypes was tracked with the MEDILIGHT App via Bluetooth. For the 
external sensors, data was recorded with the PicoLog 6 data logging software. As a 
maximal tolerable temperature on the skin surface it was decided to use a threshold 
of 40°C. An external sensor was used to track the temperature on the skin surface as 
well. For the first test on porcine skin it was possible to do point measurements every 
5 min only.  
For all experiments measurements were set into relation to each other, comparing 
the differences between the temperatures observed on the surface of the skin and on 
the flexible LED foil. The on/off times were recorded and key cycles were used for in 
vitro testing to verify the effectiveness of the cycled mode. Possible impacts of the 
temperature on the porcine skin were controlled by visual comparison with untreated 
skin. Additionally, tissue from the experimental sites was extracted and analyzed by 
histology, fixating the skin samples at RT in 37% formalin and following the 
procedure described in 2.4.9. 
 Statistical analyses 2.6
All statistical analyses were done with JMP Genomics, version 7, from SAS Institute. 
The distribution analysis was used to determine whether the data is normally 
distributed. For that the normal quantile plot and the normal distribution curve was 
used to compare the eccentricity of the data points and a Goodness of Fit test 
(Shapiro-Wilk W test) was applied. For small p-values the H0 hypothesis, where the 
data would be normally distributed, was rejected.  
For normally distributed data the Students t-test was applied; for others the non-
parametric Wilcoxon signed-rank test was used. Statistical significance was defined 
as p < 0.05. 
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3 RESULTS 
 In vitro and in vivo testing of blue light irradiation on different skin models 3.1
The effects of blue light irradiation were tested with different in vitro skin models, 
which are described in the following chapters. 
3.1.1 Irradiation of co-cultures with blue light 
Keratinocytes and fibroblasts were irradiated with different doses of blue light in a co-
culture set-up and XTT performed after separating the cells in 96-well plates. In 
Figure 24 not only the results with 41.40 J/cm² of blue light from previous work 89 are 
shown, but also the addition of 10.35 J/cm². 
 
Figure 24: XTT assay results for keratinocytes and fibroblasts from co-cultures treated with 10.35 and 
41.40 J/cm² of blue light using the Philips lamp. Assay was performed 24 h after irradiation. Data are shown 
as box plots with the median, upper and lower quartile (interquartile range (IQR)) and whiskers (1.5 x IQR). Each 
box plot represents n=3 repetitions.  
For keratinocytes doses of 10.35 J/cm² as well as 41.40 J/cm² of blue light lead to a 
decrease of metabolic activity to around 0.85 compared to the control, where the 
results for 10.35 J/cm² have a high degree of variation. For the lower dose of blue 
light the results are not significant (p = 0.8307), but for 41.40 J/cm² they are 
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significant (p < 0.0001). Fibroblasts irradiated with 10.35 J/cm² of blue light on the 
other hand show an increase of metabolic activity to 1.15 (p < 0.0001) compared to 
the control. A dose of 41.40 J/cm² of blue light on fibroblasts leads to a decrease of 
metabolic activity to 0.6 (p < 0.0001) compared to the control. 
Due to the high variance and only partial significance of these experiments, it was 
decided to take a different approach on in vitro skin models. 
3.1.2 Irradiation of mixed cultures with blue light 
As experiments on co-cultures did not result in stable results, it was decided to test 
the overall metabolic activity of both cells in a mixed culture. The main fluences of 
10.35 J/cm² and 41.40 J/cm² were tested in an XTT assay (Figure 25). 
 
Figure 25: XTT assay results of mixed cultures treated with 10.35 and 41.40 J/cm² of blue light using the 
Philips lamp. Assay was performed 24 h after irradiation. Data are shown as box plots with the median, upper 
and lower quartile (interquartile range (IQR)) and whiskers (1.5 x IQR). Each box plot represents n=3 plates with 5 
repetitions. 
The experiment revealed an increase in metabolic activity to 1.05 after irradiation with 
10.35 J/cm² and a decrease to 0.80 with 41.40 J/cm² with p-values < 0.0001 for both 
conditions. 
3.1.3 Scratch wound healing assays 
To confirm results of XTT assays, scratch wound healing assays were performed. 
While results for the XTT assays give information on metabolic activity, the scratch 
assay reveals changes in migration and proliferation of cells. First, experiments were 
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performed for mono-cultures of the respective cell lines individually and in a second 
step, cells were cultivated together and tested again in a mixed culture model.    
3.1.3.1 Scratch wound healing assays of fibroblasts  
In initial experiments, different cell concentrations (45,000; 60,000; 75,000 cells/well) 
were seeded to investigate the optimal values for this set-up (data not shown).  
The cell concentration of 60,000 cells/well led to the most stable results with a linear 
decrease in scratch size and a relatively small standard deviation, compared to other 
seeding concentrations. Therefore, the cell concentration of 60,000 cells/well and an 
incubation time of 48 h was chosen for the following experiments. 
Images were acquired at different time points after scratching, to narrow the time 
intervals required for evaluation. In Figure 26 exemplary images are shown, taken at 
0, 12, 15, 18, 21 and 24 h. Most cell proliferation takes place between 12 and 18 h, 
meaning that a time interval of 3 h between image acquisitions is not specific enough 
and had to be decreased. 
 
Figure 26: Exemplary microscopic images of fibroblasts seeded at a concentration of 60,000 cells/well 
with images taken at 0, 12, 15, 18, 21 and 24 h after creating the artificial wound. Evaluation was done with 
the AutoScratchSeg program. 
To be able to take images with shorter intervals, the IncuCyte system was used. 
Here, it was possible to acquire images while leaving cell culture plates in the 
incubator and without stressing them. Images were taken at a time interval of 1 hour 
and results where cells were irradiated with 10.35 J/cm² of blue light are shown in 
Figure 27. 
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Figure 27: Scratch assay results of NHDF cells treated with 10.35 J/cm² (7.5 min) of blue light. Evaluation of 
microscopic images was done every hour from 0 up to 23 h after the scratch and compared to the initial wound 
size (100%). Images were analyzed using the AutoScratchSeg program. Data are shown as means ± SD from 
three independent experiments with n=3 per condition and 24 images per plate. 
Differences can be seen already 1 hour after the scratch, where control cells close 
the artificial wound significantly faster than irradiated cells. This effect holds until time 
point 12 h (p < 0.05, 2 h and 10 h not significant). Differences between irradiated and 
control cells amount to 1 to 7%. Afterwards the wound sizes are nearly identical 
again and wounds are closed completely at time point 15 h for both conditions. All in 
all blue light irradiation with a dose of 10.35 J/cm² leads to a disadvantage of 1 h 
regarding wound closure. 
 
The same experiment was performed for NHDF cells, but irradiation with a dose of 
41.40 J/cm² of blue light took place (Figure 28). 
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Figure 28: Scratch assay results of NHDF cells treated with 41.40 J/cm² (30 min) of blue light. Evaluation of 
microscopic images was done every hour from 0 up to 23 h after the scratch and compared to the initial wound 
size (100%). Images were analyzed using the AutoScratchSeg program. Data are shown as means ± SD from 
three independent experiments with n=3 per condition and 24 images per plate. 
At the beginning of the experiment, only small differences can be seen. The artificial 
wound is closing linearly for both conditions in the first 8 h. After this time point the 
control cells continue closing the empty space linearly. In contrast to that, irradiated 
cells reduce this behavior. This can be seen from time points 9 to 12 h, indicated by 
significant differences (p < 0.05) of 6 to 10%. Afterwards, irradiated cells and control 
cells have the same wound sizes again without statistical significance. Artificial 
wounds are closed completely at time point 13 h for control cells, while irradiated 
wounds stay open until 16 h. This presents a difference of 3 h. 
3.1.3.2 Scratch wound healing assays of keratinocytes 
Scratch wound healing assays were also performed with mono-cultures of 
keratinocytes. For initial experiments different cell numbers were seeded, where 
300,000 cells/well and a cultivation of 24 h were chosen as the optimal parameters. 
Exemplary images are shown in Figure 29. 
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Figure 29: Exemplary microscopic images of keratinocytes seeded at a concentration of 300,000 cells/well 
at time points 0, 24, 48 and 72 h after creating the artificial wound and evaluated with AutoScratchSeg. 
Effects of 10.35 J/cm² of blue light on HaCaT cells are shown in Figure 30. 
 
Figure 30: Scratch assay results of HaCaT cells treated with 10.35 J/cm² (7.5 min) of blue light. Evaluation 
of microscopic images was done at different time points (0, 12, 18, 24, 36, 42, 48 and 72 h) after the scratch and 
compared to the initial wound size (100%). Images were analyzed using the AutoScratchSeg program. Data are 
shown as means ± SD from three independent experiments with n=3 per condition and 24 images per plate. 
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For time points 0 and 12 h there are no significant differences between irradiated and 
control HaCaT cells. First effects can be seen at time point 18 h, where irradiated 
wounds are significantly (p < 0.05) smaller by 3%. At the 24 hour time point, wounds 
have nearly the same size again. Throughout the following time points at 36, 42 and 
48 h wound sizes differ significantly (p < 0.0001) again, where irradiated HaCaT cells 
close wounds faster compared to the control. At time point 72 h both wounds are 
closed completely. The difference between irradiated and control cells amounts to 
around 9 h. 
 
The same experiment was performed for HaCaT cells with a dose of 41.40 J/cm² of 
blue light (Figure 31).  
 
Figure 31: Scratch assay results of HaCaT cells treated with 41.40 J/cm² (30 min) of blue light. Evaluation 
of microscopic images was done at different time points (0, 24, 48 and 72 h) after the scratch and compared to 
the initial wound size (100%). Images were analyzed using the AutoScratchSeg program. Data are shown as 
means ± SD from three independent experiments with n=3 per condition and 24 images per plate. 
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The results demonstrate significant differences (p < 0.0001) between irradiated and 
control cells at 24 and 48 h. The differences between the means of the curves 
amount to 10%, respectively for both time points. At time point 72 h after the scratch, 
the curves exhibit the same wound area with around 10% of the wound still open. 
Therefore the delay of wound closure adds up to 24 h. 
3.1.3.3 Scratch wound healing assays on mixed cultures  
To test whether wound healing properties change for keratinocytes and fibroblasts 
when cultivated together mixed cultures were seeded and the influence of blue light 
irradiation was investigated. 
First, different cell numbers were tested and the optimal cell concentration was 
determined (Figure 32). Cell concentrations were seeded with equal amounts of 
keratinocytes and fibroblasts, respectively. To reach confluence, a concentration of 
90,000 cells/well in total (HaCaT and NHDF cells) was required. 
 
 
Figure 32: Exemplary microscopic images of mixed cultures seeded at a concentration of 
90,000 cells/well with images taken at 0, 24 and 48 h after creating the artificial wound. Evaluation was 
done with the AutoScratchSeg program. 
After determining the optimal cell number, a treatment of 10.35 J/cm² of blue light 
was applied. Images were taken at 0, 24, 48 and 72 h. Results of artificial wound 
sizes are displayed in Figure 33. 
 
24 h after the scratch and irradiation, wound sizes stay the same for control and 
irradiated cells at 93%. At 48 h post irradiation, a significant difference can be seen, 
where the gap size of control cells is at 91% while irradiated wounds are closed to 
76% (p < 0.0001). After 72 h the wound sizes are approximately of the same size 
again with 80% for control and 85% for irradiated cells. In total, with an irradiation of 
10.35 J/cm², an advantage in wound closure of 24 h can be achieved.  
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Figure 33: Scratch assay results of mixed cultures treated with 10.35 J/cm² (7.5 min) of blue light. 
Evaluation of microscopic images was done at different time points (0, 24, 48 and 72 h) after the scratch and 
compared to the initial wound size (100%). Images were analyzed using the AutoScratchSeg program. Data are 
shown as means ± SD from three independent experiments with n=3 per condition and 24 images per plate. 
 
An irradiation with a dose of 41.40 J/cm² was tested (Figure 34). Images were 
compared at time points 0, 24 and 48 h. 
 
Significant differences were noted. For the control the wound closes linearly from 
time point 0 until 48 h. At 48 h after the scratch was performed, the artificial wound 
area is reduced by 30% of the initial size. In contrast to that, the wound area of the 
irradiated cells stays open at 100% over the whole time course. Differences are 
significant for both 24 and 48 h after the scratch (p < 0.0001). This shows an effect of 
blue light not only on the migration, but also on the proliferation of cells.  
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Figure 34: Scratch assay results of mixed cultures treated with 41.40 J/cm² (30 min) of blue light. 
Evaluation of microscopic images was done at different time points (0, 24 and 48 h) after the scratch and 
compared to the initial wound size (100%). Images were analyzed using the AutoScratchSeg program. Data are 
shown as means ± SD from three independent experiments with n=3 per condition and 24 images per plate. 
3.1.4 Short-term irradiation of non-diabetic rats with ENMECH board 
To analyse effects of the different doses identified for different wound healing stages 
in vivo, first, the individual fluences were tested on non-diabetic rats. For later 
comparison, reference values were measured for blood glucose concentrations of the 
healthy rats. Mean values for the glucose concentration is 137 mg/dL and the 
standard deviation accounts to 10 mg/dL. 
 
Plasma samples were collected processed with the Cobas c 311 analyzer. Full 
kidney and liver profiles were tested as well as CRP (Table 6). 
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Table 6: Plasma parameters of non-diabetic rats (ZDF fa/+) irradiated with different fluences of blue light. 
Baseline (n=24) was created from plasma samples taken before the experiment was started. Plasma samples for 
irradiated rats were taken 24 h post-irradiation (n=6 for each group respectively). Data are expressed as means 
± SD. Values significantly different from the baseline are indicated as *p < 0.05, **p < 0.01.  
Parameter Baseline 
Fluence [J/cm²] 
0.00 10.35 41.40 82.80 
ALT 
[U/L] 
35 ± 14 52 ± 34 22 ± 15 34 ± 21 37 ± 9 
AST 
[U/L] 
78 ± 16 221  ± 184* 141 ± 52** 148 ± 116* 125 ± 33** 
Calcium 
[mmol/L] 
2.68 ± 0.08 2.65 ± 0.05 2.62 ± 0.09 2.68 ± 0.06 2.66 ± 0.05 
Cholesterol 
[mg/dL] 
102 ± 8 93 ± 2* 92 ± 2** 90 ± 8* 94 ± 6* 
Creatinine 
[mg/dL] 
0.28 ± 0.04 0.26  ± 0.03 0.30 ± 0.04 0.24 ± 0.05 0.25 ± 0.02 
GLDH 
[U/L] 
9.72 ± 6.59 7.75 ± 2.23 8.55 ± 1.90 7.98 ± 1.70 10.17 ± 1.64 
Potassium 
[mmol/L] 
4.67 ± 0.35 4.60 ± 0.19 4.56 ± 0.13 4.90 ± 0.63 4.62 ± 0.44 
Sodium 
[mmol/L] 
141 ± 2 141 ± 1 141 ± 2 142 ± 2 142 ± 3 
Phosphate 
[mmol/L] 
2.03 ± 0.20 2.00 ± 0.06 1.98 ± 0.08 2.02 ± 0.20 2.05 ± 0.14 
Protein 
[mg/dL] 
63 ± 3 60 ± 1* 62 ± 5 61 ± 2 62 ± 3 
Triglycerides 
[mg/dL] 
97 ± 30 77 ± 30 99 ± 25 87 ± 29 76 ± 23 
Urea 
[mg/dL] 
39.0 ± 2.7 36.3 ± 3.2 36.2 ± 3.3 36.6 ± 4.4 35.8 ± 2.6* 
 
Differences can be seen for AST. AST is significantly increased for all groups post-
treatment including control animals that were not irradiated. For control animals AST 
is increased by 3-fold (p < 0.05) and for all irradiated groups it is increased by 2-fold 
(p < 0.05 for 41.40 J/cm² and p < 0.01 for 10.35 J/cm² and 82.80 J/cm²). 
Also cholesterol levels differ for all groups. Cholesterol is significantly decreased by 
approximately 10% (p < 0.01).  
Some small changes can be seen for protein, where control rats have a significantly 
decreased protein concentration after the experiment compared to the baseline. The 
decrease amounts to 5% and is significant with p < 0.05.  
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Another parameter, urea, is decreased after treatment, but only for rats that received 
82.80 J/cm² of blue light. The concentration is decreased by 8% (p < 0.05). 
 
An ELISA test for the CRP concentration was performed (Figure 35). 
 
Figure 35: CRP concentration in rat plasma determined by ELISA of non-diabetic rats (ZDF fa/+). Samples 
were taken for all rats on day 0 before single irradiation with fluences of 10.35, 41.40, 82.80 J/cm² or no irradiation 
followed. 24 h post light treatment samples were taken again. Data are shown as box plots with the median, 
upper and lower quartile (interquartile range (IQR)) and whiskers (1.5 x IQR). Each box plot represents n=6 
plasma samples.  
The baseline CRP concentration was 0.22 mg/dL at time point 0 h before wounding. 
After 24 h the CRP increased to 0.27 mg/dL for control rats as well as for rats treated 
with 41.40 and 82.80 J/cm² of blue light. A small difference can be noticed when rats 
were treated with a dose of 10.35 J/cm² of blue light, where the CRP concentration 
drops to 0.23 mg/dL compared to other fluences. This concentration is nearly the 
same as for the baseline and is even lower than control rats after the experiment, but 
without statistical significance due to high standard deviation. 
At the end of the experiment, skin samples were taken, embedded in paraffin, sliced 
and stained with H&E (section 2.4.9). These histology slides were imaged with the 
Axio Scan. First, the area of the inflammatory site was compared between groups 
(Figure 36). Criteria of identifying the inflammatory site were the lack of thick collagen 
fibers and increased presence of leukocytes and fibrin. 
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Figure 36: Results of image evaluation by ilastik segmentation are shown, divided into either control 
groups or irradiation with 10.35, 41.40 or 82.80 J/cm² of blue light. Data are displayed in mm² with means ± 
SD. Each group represents values from n=6 animals. 
Areas of the groups do not differ significantly due to high standard deviations. The 
control group and groups irradiated with 10.35 J/cm² and 82.80 J/cm² have an 
inflammatory area of 1.0 to 1.3 mm². The group irradiated with 41.40 J/cm² shows a 
decrease to 0.54 mm² (p = 0.0656).  
 
After determining the area of the inflammatory sites, they were inspected in regard to 
their fibrin and leukocyte content. As there are no significant differences between the 
four groups, data is not shown.  
 
With another approach, possible differences between the groups were investigated, 
not considering the covered area by leukocytes, but the number of leukocytes in 
relation to the inflammatory site (Figure 37). 
Significant differences between groups cannot be seen. With 11,000 leukocytes/mm² 
the control group and groups irradiated with 10.35 and 41.40 J/cm² have nearly the 
same number of leukocytes per mm². Animals irradiated with 82.80 J/cm² show a 
decrease of leukocytes per mm² with around 8,500 (p = 0.0712). 
No differences between non-irradiated wounds of irradiated animals and the control 
wounds of non-irradiated animals could be seen, therefore the data is not shown.  
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Figure 37: Results of image evaluation by ilastik segmentation are shown, divided into either control 
groups or irradiation with 10.35, 41.40 or 82.80 J/cm² of blue light. Data are displayed in number per area in 
mm² with means ± SD in relation to the area of the respective inflammatory site. Each group represents values 
from n=6 animals. 
Gene set enrichment analysis (GSEA) was performed according to section 2.4.7. 
Selected genes were sorted into expression patterns according to the KEGG 
database and a ranked list was created. By comparing the normalized enrichment 
scores (NES) up- and down-regulated pathways were identified (Table 7). 
Table 7: Overview of GSEA displaying the numbers of deregulated pathways for rats irradiated with 
10.35 J/cm² (7.5 min), 41.40 J/cm² (30 min) and 82.80 J/cm² (60 min) of blue light. Genes were sorted into a 
total of 313 pathways. Fluorescence intensities of light treated samples are normalized to the control. Level of 
significances was defined as p ≤ 0.05 for nominal and adjusted (FDR ≤ 0.25) p-values respectively. 
Fluence 10.35 J/cm² 41.40 J/cm² 82.80 J/cm² 
Pathways containing up-regulated genes 163 203 83 
Significantly up-regulated pathways 
(nominal p-value < 0.05) 
38 66 18 
Significantly up-regulated pathways 
(adjusted p-value < 0.05) 
8 41 13 
Pathways containing down-regulated genes 150 110 230 
Significantly down-regulated pathways 
(nominal p-value < 0.05) 
22 30 76 
Significantly down-regulated pathways 
(adjusted p-value < 0.05) 
2 19 41 
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For 10.35 J/cm² and 41.40 J/cm² of blue light there is a shift to more pathways being 
up-regulated. For 82.80 J/cm² of blue light it is the opposite: more pathways are 
down-regulated. 
In a further step, deregulated pathways with an adjusted p-value ≤ 0.05 were 
analysed in detail. KEGG sorts gene sets into 6 main categories. The distribution of 
pathways that are significantly deregulated according to these main categories is 
shown in Figure 38. 
 
Figure 38: Pie chart showing the distribution of pathways containing significantly up- and down-regulated 
genes sorted by main categories of KEGG. Groups are formed by the respective fluences/irradiation times. 
The numbers around the pie charts indicate the number of deregulated pathways contained in each category. 
Pathways belonging to the main category ‘Metabolism’ seem to be down-regulated 
strongest with 41.40 J/cm² and less so with 82.80 J/cm². ‘Genetic Information 
Processing’ is slightly up-regulated already with a fluence of 10.35 J/cm². Higher 
fluences increase the up-regulation of pathways belonging to this category with 
9 pathways up-regulated with 41.40 J/cm² and 10 pathways up-regulated with 
82.80 J/cm². The category ‘Environmental Information Processing’ is down-regulated 
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with 10.35 J/cm² and is down-regulated by a higher extent with 41.40 J/cm² 
(7 pathways) and 82.80 J/cm² (9 pathways). 10.35 J/cm² of blue light cause an up-
regulation of cellular processes (3 pathways), and 41.40 J/cm² an even stronger 
effect with 4 pathways up-regulated. 82.80 J/cm² of blue light cause only a slight up-
regulation of cellular processes (1 pathway). Pathways related to organismal systems 
and human diseases are strongly down-regulated for 41.40 J/cm² and 82.80 J/cm². 
The KEGG database further divides the main categories in subcategories. To get a 
clearer picture of which processes are affected by blue light, the significantly 
deregulated pathways are displayed according to these subgroups.  
In Figure 39 the main category ‘Metabolism’ with the corresponding deregulated 
subcategories is shown.  
 
Figure 39: Main category “Metabolism’ with subcategories containing deregulated pathways. The fluence 
and irradiation time is depicted by the NES. Values > 0 (< 0) indicate an up-regulation (down-regulation). Bar 
charts are shown with the mean and ± standard deviation. As not all pathways were significantly deregulated for 
each fluence and subcategory they were added for a complete summary. The distinction between up- and down-
regulation was not made to get a better overview; therefore standard deviations can be high, if subcategories 
contain both significantly up- and down-regulated pathways.  
While 10.35 J/cm² and 41.40 J/cm² induce down-regulation of global and overview 
maps, for 82.80 J/cm² of blue light expression remains unchanged. Energy 
metabolism is down-regulated for all fluences with the strongest effect at 41.40 J/cm². 
Glycan biosynthesis and metabolism is up-regulated for both 10.35 J/cm² and 
41.40 J/cm² and is down-regulated for 82.80 J/cm². 
The individual significantly up- and down-regulated pathways associated with the 
subcategories are summarized in Table 8. 
By irradiation with 41.40 J/cm² metabolic pathways were down-regulated. The carbon 
metabolism as well as the biosynthesis of amino acids was found to be down-
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regulated by this fluence as well. Oxidative phosphorylation was also down-regulated 
with higher fluences. The glycan biosynthesis was found to be up-regulated by a 
fluence of 41.40 J/cm² and the degradation down-regulated with 82.80 J/cm². 
Table 8: Significantly deregulated pathways belonging to KEGG’s main category ‘Metabolism’. The main 
category is divided into 13 subcategories. Three of these categories contain significantly deregulated pathways, 
which are shown in the table with their respective NES and adjusted p-values. Up-regulated pathways are 
indicated by the positive NES colored in red and down-regulated pathways are indicated by the negative NES 
colored in green.  
 
In the main category ‘Genetic Information Processing’, pathways of all subcategories 
are slightly up-regulated with 10.35 J/cm² and significantly stronger up-regulated with 
higher fluences. An overview graph is shown in Figure 40. 
 
Figure 40: Main category ‘Genetic Information Processing’ with subcategories containing deregulated 
pathways. The fluence and irradiation time is depicted by the NES. Values > 0 (< 0) indicate an up-regulation 
(down-regulation). Bar charts are shown with the mean and ± standard deviation. As not all pathways were 
significantly deregulated for each fluence and subcategory they were added for a complete summary. The 
distinction between up- and down-regulation was not made to get a better overview; therefore standard deviations 
can be high, if subcategories contain both significantly up- and down-regulated pathways. 
The individual significantly up- and down-regulated pathways associated with the 
subcategories are summarized in Table 9. 
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Table 9: Significantly deregulated pathways belonging to KEGG’s main category ‘Genetic Information 
Processing’. The main category is divided into 4 subcategories; all of the categories contain significantly 
deregulated pathways, which are shown in the table with their respective NES and adjusted p-values. Up-
regulated pathways are indicated by the positive NES colored in red and down-regulated pathways are indicated 
by the negative NES colored in green. 
 
In the first subcategory ‘2.1. Transcription’, the splicing process is significantly up-
regulated. Also translation processes are mostly up-regulated except for the 
ribosome biogenesis after irradiation with 41.40 J/cm² of blue light. In the 
subcategory of ‘2.3. Folding, sorting and degradation’, proteolysis, vesicular transport 
and protein processing are up-regulated. Pathways associated with replication and 
repair were also found to be up-regulated.  
 
In Figure 41 the main category ‘Environmental Information Processing’ with the 
corresponding deregulated subcategories is shown.  
Pathways belonging to the signal transduction are up- and down-regulated with 
10.35 J/cm², resulting in no overall change. With 41.40 J/cm² and 82.80 J/cm² down-
regulation of pathways of this subcategory is induced. Pathways of the subcategory 
‘3.3. Signaling molecules and interaction’ are up-regulated at 10.35 J/cm², 
41.40 J/cm² shows no change while containing up- and down-regulated pathways 
and is down-regulated for 82.80 J/cm². 
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Figure 41: Main category ‘Environmental Information Processing’ with subcategories containing 
deregulated pathways. The fluence and irradiation time is depicted by the NES. Values > 0 (< 0) indicate an up-
regulation (down-regulation). Bar charts are shown with the mean and ± standard deviation. As not all pathways 
were significantly deregulated for each fluence and subcategory they were added for a complete summary. The 
distinction between up- and down-regulation was not made to get a better overview; therefore standard deviations 
can be high, if subcategories contain both significantly up- and down-regulated pathways. 
The individual significantly up- and down-regulated pathways associated with the 
subcategories are summarized in Table 10. 
Table 10: Significantly deregulated pathways belonging to KEGG’s main category ‘Environmental 
Information Processes’. The main category is divided into 3 subcategories. Two of the categories contain 
significantly deregulated pathways, which are shown in the table with their respective NES and adjusted p-values. 
Up-regulated pathways are indicated by the positive NES colored in red and down-regulated pathways are 
indicated by the negative NES colored in green. 
 
The subcategory ‘3.2. Signal transduction’ shows that for 10.35 J/cm² only the AMPK 
signaling pathway is significantly down-regulated. For higher fluences all other 
pathways are significantly down-regulated. The third subcategory shows down-
regulation of cell adhesion molecules for 10.35 J/cm², while for 41.40 J/cm² 
neuroactive ligand-receptor interaction is down-regulated.  For 82.80 J/cm² the same 
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pathway is down-regulated, but to a higher extent. Also the viral protein interaction 
with cytokines is down-regulated.  
In Figure 42 the main category ‘Cellular Processes’ with the corresponding 
deregulated subcategories is shown.  
 
Figure 42: Main category ‘Cellular Processes’ with subcategories containing deregulated pathways. The 
fluence and irradiation time is depicted by the NES. Values > 0 (< 0) indicate an up-regulation (down-regulation). 
Bar charts are shown with the mean and ± standard deviation. As not all pathways were significantly deregulated 
for each fluence and subcategory they were added for a complete summary. The distinction between up- and 
down-regulation was not made to get a better overview; therefore standard deviations can be high, if 
subcategories contain both significantly up- and down-regulated pathways. 
For the subcategory ‘4.1. Transport and catabolism’ the differential expression of 
genes by  10.35 J/cm² results in no overall change. For 41.40 J/cm² there is a slight 
up-regulation and for 82.80 J/cm² a slight down-regulation. The significantly up- or 
down-regulated pathways belonging to this main category are summarized in 
Table 11. 
Table 11: Significantly deregulated pathways belonging to KEGG’s main category ‘Cellular Processes’. 
The main category is divided into 5 subcategories. Two of the categories contain significantly deregulated 
pathways, which are shown in the table with their respective NES and adjusted p-values. Up-regulated pathways 
are indicated by the positive NES colored in red and down-regulated pathways are indicated by the negative NES 
colored in green. 
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Lysosomal transport and catabolism is down-regulated for 82.80 J/cm². For 
phagosomes these processes are up-regulated for 10.35 J/cm² and 41.40 J/cm². 
Additionally with 41.40 J/cm² transport related to peroxisomes is down-regulated. 
Concerning the subcategory ‘4.2. Cell growth and death’ the cell cycle and the 
p53 signaling pathway are up-regulated for all fluences. 
The main category ‘Organismal Systems’ is divided into 10 subcategories. 5 of these 
subcategories contain deregulated pathways, which are shown in Figure 43. 
 
Figure 43: Main category ‘Organismal Systems’ with subcategories containing deregulated pathways. The 
fluence and irradiation time is depicted by the NES. Values > 0 (< 0) indicate an up-regulation (down-regulation). 
Bar charts are shown with the mean and ± standard deviation. As not all pathways were significantly deregulated 
for each fluence and subcategory they were added for a complete summary. The distinction between up- and 
down-regulation was not made to get a better overview; therefore standard deviations can be high, if 
subcategories contain both significantly up- and down-regulated pathways. 
Pathways for the regulation of the immune system appear to be up-regulated by 
10.35 J/cm², while for 41.40 J/cm² and 82.80 J/cm² the pathways are mostly down-
regulated. The endocrine and digestive systems are down-regulated for all fluences 
with the strongest down-regulation at 82.80 J/cm². The nervous system and the 
environmental adaptation are also down-regulated for all fluences, but the strongest 
down-regulation is achieved with 41.40 J/cm².  
To analyze the significantly deregulated pathways in detail, a summary table was 
created (Table 12). 
Changes in gene expression of the immune system with 10.35 J/cm² appears by the 
up-regulation of the leukocyte transendothelial migration. For 82.80 J/cm² the toll-like 
receptor signaling and the cytosolic DNA-sensing pathway are down-regulated. 
For the endocrine system the melanogenesis and aldosterone synthesis and 
secretion is down-regulated for 41.40 J/cm² and 82.80 J/cm². Also the thyroid 
hormone signaling pathway is down-regulated for 82.80 J/cm². 
Results 
58 
Table 12: Significantly deregulated pathways belonging to KEGG’s main category ‘Organismal Systems’. 
The main category is divided into 10 subcategories. Five of the categories contain significantly deregulated 
pathways, which are shown in the table with their respective NES and adjusted p-values. Up-regulated pathways 
are indicated by the positive NES colored in red and down-regulated pathways are indicated by the negative NES 
colored in green. 
 
Relevant pathways belonging to the digestive system are the pancreatic secretion, fat 
digestion and absorption, and bile secretion, which are down-regulated for 
82.80 J/cm². 41.40 J/cm² show a significant effect on the nervous system, where 
pathways of long-term potentiation, retrograde endocannabinoid signaling and 
cholinergic synapse are down-regulated. In the subcategory of environmental 
adaptation, thermogenesis is down-regulated for all fluences. 
In the main category ‘Human Diseases’ 12 subcategories are listed in KEGG of which 
four were found to be deregulated after irradiation with blue light (Figure 44). Immune 
diseases are up-regulated by all fluences with the strongest effect after 10.35 J/cm² 
of blue light. Neurodegenerative, endocrine and metabolic diseases are down-
regulated for all fluences as well, but with the strongest effect after 41.40 J/cm². 
Pathways linked to bacterial infectious diseases are up-regulated by 10.35 J/cm² and 
less so by 41.40 J/cm². 82.80 J/cm² of blue light induces the opposite, where 
pathways connected to bacterial infectious diseases are down-regulated. 
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Figure 44: Main category ‘Human Diseases’ with subcategories containing deregulated pathways. The 
fluence and irradiation time is depicted by the NES. Values > 0 (< 0) indicate an up-regulation (down-regulation). 
Bar charts are shown with the mean and ± standard deviation. As not all pathways were significantly deregulated 
for each fluence and subcategory they were added for a complete summary. The distinction between up- and 
down-regulation was not made to get a better overview; therefore standard deviations can be high, if 
subcategories contain both significantly up- and down-regulated pathways. 
A summary list of all pathways deregulated in the main category ‘Human Diseases’ 
divided by their subcategory is shown in Table 13. 
Table 13: Significantly deregulated pathways belonging to KEGG’s main category ‘Human Diseases’. The 
main category is divided into 12 subcategories. Four of the categories contain significantly deregulated pathways, 
which are shown in the table with their respective NES and adjusted p-values. Up-regulated pathways are 
indicated by the positive NES colored in red and down-regulated pathways are indicated by the negative NES 
colored in green. 
 
In the category of immune diseases, pathways of systemic lupus erythematosus are 
up-regulated for all fluences. Neurodegenerative diseases as Alzheimer, Parkinson 
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and Huntington disease are down-regulated for 41.40 J/cm² and 82.80 J/cm². 
Endocrine and metabolic diseases as type II diabetes, insulin resistance and non-
alcoholic fatty liver disease are down-regulated for the same fluences. For bacterial 
infectious diseases the bacterial invasion of epithelial cells is up-regulated for 
10.35 J/cm² and 41.40 J/cm². Pertussis and Tuberculosis are down-regulated with 
82.80 J/cm². 
3.1.5 Long-term irradiation of diabetic and non-diabetic rats with ENMECH board  
After single irradiations were tested on animals, a schedule for light therapy was 
generated (Table 14).  
Table 14: Light schedule for long-term irradiation as a possible therapy against diabetic foot ulcers. 
 
The light schedule includes all irradiation times that were tested in short-term 
experiments (section 3.1.4). Every phase was tested for 3 consecutive days. ZDF 
fa/fa rats were fed with a special diet causing diabetes. To follow the progress of the 
disease blood glucose concentrations were tested weekly (Figure 45).  
 
Figure 45: Blood glucose concentrations [mg/dL] of rats which are to be irradiated over the course of 
12 days. The graph shows values for diabetic rats (fa/fa) in red and for healthy rats (fa/+) in blue. The 
measurements started shortly after arrival of the rats and continued until the end of the experiment. Data are 
displayed as mean values ± SD with n=18 animals. 
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As a reference ZDF fa/+ rats were included. For healthy ZDF fa/+ rats gaps between 
measurements were bigger due to stable results throughout the experiment. The 
glucose concentration of ZDF fa/fa rats is steadily increasing over time, starting at 
approximately 280 mg/dL at the age of 8 weeks. The peak is reached at the age of 
12 weeks with a concentration of 550 mg/dL. These rising glucose levels are 
accompanied by polyuria and polydipsia  
 
After wounding with a biopsy punch (6 mm), images of the wounds were taken daily. 
The images were analysed with Fiji by using the freehand selection to measure the 
area of the wound in pixels. The area in pixels was then converted into mm²; the 
areas were divided by the initial wound areas to obtain percentages (Figure 46). 
 
Figure 46: Wound areas displayed in % normalized to the wound area on day 1 (D = Diabetic ZDF fa/fa, 
LED = Light therapy). Rats were irradiated with blue light according to the light schedule: 82.80 J/cm² on day 
1-3, 41.40 J/cm² on day 4-6, 10.35 J/cm² on day 7-9 and 10.35 J/cm² on day 11. Each curve represents n=6, data 
are displayed as mean values ± SD. 
During irradiation with 82.80 and 41.40 J/cm² of blue light, there is no significant 
difference of the wound areas compared to the control rats. As soon as irradiation 
with 10.35 J/cm² starts, the wounds close faster for rats receiving the light treatment. 
On day 8 there is a significant difference of 20% (p < 0.05) and on day 9 of 10%, 
which is not significant. On days 10 to 13 the difference of wound areas is about 15% 
with statistical significance throughout (days 10 to 12 with p < 0.05 and day 13 with 
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p < 0.01). The wound area of control rats on day 13 approximately corresponds to 
the wound area of irradiated rats on day 10, revealing an advantage of 3 days when 
applying the light therapy. 
 
Furthermore, the third group with non-diabetic rats was compared to diabetic rats, 
both receiving light treatment (Figure 47).  
 
Figure 47: Wound areas displayed in % normalized to the wound area on day 1 (D = Diabetic ZDF fa/fa, ND 
= Non-diabetic ZDF fa/+, LED = Light therapy). Rats were irradiated with blue light according to the light 
schedule: 82.80 J/cm² on day 1-3, 41.40 J/cm² on day 4-6, 10.35 J/cm² on day 7-9 and 10.35 J/cm² on day 11. 
Each curve represents n=6, data are displayed in means ± SD. 
Here, the wounds of non-diabetic rats healed faster on day 1 to 9 compared to 
diabetic rats. The differences are significant on days 5 to 7 with a significance of 
p < 0.05. Between day 9 and 10 the wounds are equal in size and afterwards the 
wounds of diabetic rats are smaller on day 11 and 12 without statistical significance. 
On the last day of the experiment wound areas are identical in size. 
To analyse possible systemic effects, non-irradiated wounds of irradiated animals 
and the wounds of non-irradiated animals were compared. No differences could be 
seen; therefore the data is not shown.  
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Possible biochemical changes in plasma were tested with the Cobas c 311 analyzer. 
A full overview plasma profile was created including kidney and liver function profiles 
(Table 15).  
Table 15: Plasma parameters of diabetic and non-diabetic rats irradiated with complete light schedule. 
Baseline (n=12 (D), n=6 (ND)) was created from plasma samples taken before the experiment was started on 
day 1. Plasma samples for irradiated rats were taken 24 h after the last irradiation on day 13. Data are expressed 
as means ± SD. Values significantly different are indicated as *p < 0.05, **p < 0.01, ***p <0.001. Comparisons on 
day 1 were done between non-diabetic and diabetic rats (ZDF fa/+ and ZDF fa/fa). Comparisons on day 13 were 
done in relation to their respective baseline on day 1. 
Plasma 
parameter 
Time point 
[days] 
ZDF fa/+ rats 
Irradiated 
ZDF fa/fa rats 
Control 
ZDF fa/fa rats 
Irradiated 
ALT 
[U/L] 
1 38 ± 9 185 ± 134*** 
13 48 ± 8 75 ± 76* 53 ± 43** 
AST 
[U/L] 
1 77 ± 2 140 ± 109 
13 105 ± 24** 99  ± 47 74 ± 19 
Calcium 
[mmol/L] 
1 2.72 ± 0.09 2.56 ± 0.56 
13 2.64 ± 0.08 2.76 ± 0.19 2.85 ± 0.10 
Cholesterol 
[mg/dL] 
1 94 ± 6 127 ± 35 
13 98 ± 6 121 ± 24 129 ± 15 
Creatinine 
[mg/mL] 
1 0.27 ± 0.03 0.19 ± 0.06*** 
13 0.28 ± 0.03 0.21 ± 0.03 0.19 ± 0.03 
GLDH 
[U/L] 
1 12.64 ± 8.64 79.36 ± 81.79* 
13 7.98 ± 3.74 38.57 ± 33.34 23.37 ± 15.48 
Phosphate 
[mmol/L] 
1 2.13 ± 0.24 2.37 ± 0.15* 
13 2.04 ± 0.16 2.35 ± 0.23 2.29 ± 0.15 
Potassium 
[mmol/L] 
1 4.67 ± 0.34 5.40 ± 1.03 
13 4.56 ± 0.31 4.25 ± 0.26*** 4.34 ± 0.22** 
Protein 
[mg/mL] 
1 63 ± 3 61 ± 11 
13 62 ± 3 66 ± 5 66 ± 3 
Sodium 
[mmol/L] 
1 144 ± 3 125 ± 25*** 
13 146 ± 4 137 ± 9* 138 ± 2 
Triglycerides 
[mg/dL] 
1 73 ± 13 447 ± 142*** 
13 88 ± 39 302 ± 47** 303 ± 38* 
Urea 
[mg/dL] 
1 41.5 ± 2.1 51.0 ± 4.0** 
13 46.9 ± 3.6* 45.2 ± 3.0* 46.8 ± 2.1 
First, we compare the baselines, where plasma samples were taken before the start 
of the experiment for diabetic and healthy rats respectively, to evaluate if a diabetic 
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model was successfully implemented. Changes can be seen regarding ALT, which is 
significantly increased (p < 0.001) by 2-fold for diabetic rats. Further, GLDH, an 
indicator for liver damage, is significantly increased (p < 0.05) for diabetic rats by 
6-fold as well as triglycerides (p < 0.001). Compared to healthy rats, also phosphate 
is significantly increased (p < 0.05) by 11% and urea (p < 0.01) by 23%. Lastly, 
creatinine, a kidney retention parameter, is significantly decreased (p < 0.001) by 
30% as well as sodium (p < 0.001) by 13% for diabetic rats.  
When comparing values for control and irradiated healthy rats, significant increases 
for AST by 36% (p < 0.01) and urea by 13% (p < 0.05) can be seen. 
For diabetic controls, plasma parameters were compared before and after the 
experiment, to be able to estimate the influence of the experimental procedures. 
Decreases for ALT by 60% (p < 0.05), potassium by 21% (p < 0.001), triglycerides by 
32% (p < 0.01) and urea by 11% (p < 0.05) can be noticed, as well as an increase in 
sodium concentration by 10% (p < 0.05). 
The same effects can be seen when comparing irradiated diabetic rats to their 
control: there are decreases for ALT by 71% (p < 0.01), potassium by 20% (p < 0.01) 
and triglycerides by 32% (p < 0.05). In summary there are no differences between 
irradiated diabetic and control rats after the end of the experiment. 
Additionally ELISA for rat CRP was performed (Figure 48). 
 
Figure 48: CRP concentration in rat plasma determined by ELISA of control (D) and light treated groups of 
diabetic rats (D+LED) and a light treated group of non-diabetic rats (ND+LED) in a long-term experiment. 
Samples were taken on day 1 and 13 indicated by the number in brackets. Data are shown as box plots with the 
median, upper and lower quartile (interquartile range (IQR)) and whiskers (1.5 x IQR). Each box plot represents 
n=6 plasma samples.  
Results 
65 
CRP results show significant differences between healthy and diabetic rats before the 
start of the experiment. While healthy rats have a normal CRP concentration of 
0.24 mg/dL, the concentration of diabetic rats is increased to 0.33 mg/dL (i.e. +38%, 
p < 0.0001). Healthy rats do not show a significant difference after irradiation 
compared to their control. CRP concentrations of diabetic rats without treatment 
significantly drop to 23 mg/dL (p < 0.001) as well as for rats with light treatment to 
28 mg/dL (p < 0.001). There is no significant difference between diabetic irradiated 
and control rats though. 
 
Skin samples were taken from the wound site, embedded in paraffin, sliced and 
stained with H&E. Images were evaluated with the image segmentation software 
ilastik. First, thickness of the epidermis was compared between groups (Figure 49). 
 
Figure 49: Results of image evaluation by ilastik segmentation. Data are displayed in µm with means ± SD. 
Each group represents values from n=6 animals. 
The epidermal thicknesses of the groups do not differ significantly. A trend can be 
seen, where the skin of irradiated diabetic rats is slightly thinner (p = 0.0983) 
compared to non-irradiated rats. Thickness of the epidermis of non-diabetic rats that 
received light treatment is the same as for diabetic control rats, showing a similar 
difference compared to diabetic irradiated rats (p = 0.0895). 
 
The inflammatory site of the injury was examined in respect to its area. Properties of 
identifying the inflammatory site were the lack of thick collagen fibers, increased 
Results 
66 
presence of leukocytes and fibrin. The areas of the different groups are compared in 
Figure 50. 
 
Figure 50: Results of image evaluation by ilastik segmentation. Data are displayed in mm² with means ± SD. 
Each group represents values from n=6 animals. 
Areas of the groups do not differ significantly. Trends can be noticed, when groups of 
diabetic control and irradiated rats are compared.  
 
In Figure 51 areas that are covered by fibrin and leukocytes are shown in relation to 
the inflammatory site. 
For both parameters no significant changes can be detected, but again, trends can 
be identified. Both diabetic groups have the same area covered by fibrin with around 
2%. The non-diabetic group has a lower fibrin content with only 0.5% (p = 0.0523). 
For percentages of leukocytes a similar trend is observed, but again, without 
statistical significance.  
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Figure 51: Results of image evaluation by ilastik segmentation. Data are displayed in % with means ± SD 
and were set in relation to the area of the inflammatory site of histological skin samples. Each group represents 
values from n=6 animals. 
Another approach was tried to investigate possible differences between the groups, 
not considering the covered area by leukocytes, but the number of leukocytes in 
relation to the area (Figure 52). 
 
Figure 52: Results of image evaluation by ilastik segmentation Data are displayed in number per area in mm² 
with means ± SD in relation to the area of the respective inflammatory site. Each group represents values from 
n=6 animals. 
Again, no statistical significance was detected.  
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No differences between non-irradiated wounds of irradiated animals and the control 
wounds of non-irradiated animals could be seen, therefore the data is not shown and 
no further analysis was pursued. 
 
To study the effects of long-term blue light irradiation in detail, GSEA was performed 
by using the RNA of skin tissue samples. A ranked list was created and the number 
of significantly deregulated pathways were summarized in Table 16.  
Only 3 genes were found to be significantly differentially expressed when comparing 
the diabetic control and diabetic light treated group. More pathways are up-regulated 
than down-regulated where 82 pathways are significantly up-regulated and 19 
significantly down-regulated with an adjusted p-value of < 0.05. 
Table 16: Overview of GSEA displaying the numbers of deregulated pathways for diabetic and non-
diabetic rats treated with the complete light schedule. Genes were sorted in a total of 313 pathways. 
Fluorescence intensities of light treated samples are normalized to the control. Level of significances was defined 
as p ≤ 0.05 for nominal and adjusted p-values (FDR ≤ 0.25) respectively. 
 Diabetic control  
vs.  
Diabetic BL 
Diabetic BL  
vs. 
 Non-diabetic BL 
Significantly differentially expressed genes 3 122 
Significantly up-regulated genes 0 31 
Pathways containing up-regulated genes 210 211 
Significantly up-regulated pathways  
(nominal p-value < 0.05) 
106 152 
Significantly up-regulated pathways  
(adjusted p-value < 0.05) 
82 143 
Significantly down-regulated genes 3 91 
Pathways containing down-regulated genes 103 102 
Significantly down-regulated pathways  
(nominal p-value < 0.05) 
26 48 
Significantly down-regulated pathways  
(adjusted p-value < 0.05) 
19 46 
 
Comparing the diabetic light treated with the non-diabetic light treated group shows 
the same pattern, where more pathways are up-regulated than down-regulated. With 
a number of 122, more genes are significantly differentially expressed. Also more 
pathways are significantly up- and down-regulated, respectively, comparing by the 
adjusted p-value, but there are still more pathways up-regulated than down-
regulated. 
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To better compare the deregulated pathways between the groups, the KEGG main 
categories were chosen as a criterion. The pathways are sorted into these 
6 categories and separated by up- and down-regulation and the individual group 
comparisons (Figure 53). 
 
Figure 53: Pie chart showing the distribution of pathways containing significantly up- and down-regulated 
genes sorted by main categories of KEGG. Groups are formed by the respective conditions of diabetic (DB) or 
non-diabetic (NDB) rats and animals which received the light treatment (BL) or their control (C). The numbers 
around the pie charts indicate the number of deregulated pathways contained in each category. 
In the comparison of control and light treated diabetic rats it is noticeable that most 
pathways are down-regulated belonging to the main categories 'Metabolism' and 
'Genetic Information Processing' with 15 and 17 pathways. Mostly up-regulated 
pathways belong to the group of 'Organismal Systems' and 'Human Diseases' with 45 
and 52 pathways. Also the categories of ‘Metabolism’, ‘Environmental Information 
Processing’ and ‘Cellular Processes’ have 10-20 up-regulated pathways. 
When comparing the non-diabetic and diabetic light treated groups, the distribution of 
up- and down-regulated pathways between the categories is nearly the same, but 
with less individually deregulated pathways. 
As only basic information can be gathered from this graph, summary tables were 
created, which indicate the deregulated pathways. The main categories were divided 
into KEGG's subcategories and the individual pathways shown.  
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Table 17 shows selected deregulated pathways of the main category ‘Metabolism’; 
the complete list can be found in chapter ‘7 Appendix’ in Table 24. 
Table 17: Selected significantly deregulated pathways belonging to KEGG’s main category ‘Metabolism’. 
The main category is divided into 13 subcategories. Six of these categories were selected which contain 
significantly deregulated pathways. They are depicted with their respective NES and adjusted p-values. Up-
regulated (Down-regulated) pathways are indicated by the positive (negative) NES colored in red (green). 
Comparisons were done by the respective conditions of diabetic (DB) or non-diabetic (NDB) rats and animals 
which received the light treatment (BL) or their control (C). 
 
 
Many pathways were deregulated after long-term treatment with blue light.  Where 
the fatty acid metabolism and nearly all pathways belonging to the lipid metabolism 
were found to be down-regulated, carbohydrate, nucleotide, amino acid and glycan 
metabolism were up-regulated. When comparing non-diabetic and diabetic light 
treated groups, only few pathways were significantly deregulated, e.g. fatty acid, 
steroid, sphingolipid, purine and glycan metabolism. 
In the main category ‘Genetic Information Processing’ consisting of 4 subcategories, 
3 were found to be significantly down-regulated. The affected pathways are the 
spliceosome, ribosome and its biogenesis, RNA degradation and proteasome. 
Changes in the fourth subcategory ‘Replication and repair’ were expected due to the 
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results of the short-term irradiation, but could only be found for the comparison of 
non-diabetic and diabetic light treated groups (full data set is shown in Table 25, 
chapter 7 Appendix) 
Table 18: Selected significantly deregulated pathways belonging to KEGG’s main category ‘Genetic 
Information Processing’. The main category is divided into 4 subcategories. Three of these categories were 
selected which contain significantly deregulated pathways. They are depicted with their respective NES and 
adjusted p-values. Up-regulated pathways are indicated by the positive NES colored in red and down-regulated 
pathways are indicated by the negative NES colored in green. Comparisons were done by the respective 
conditions of diabetic (DB) or non-diabetic (NDB) rats and animals which received the light treatment (BL) or their 
control (C). 
 
The category ‘Environmental Information Processes’ shows increases in expression 
patterns concerning signal transduction and signalling molecules (selected pathways 
are shown in Table 19, full data set is shown in Table 26, chapter 7 Appendix). 
Table 19: Selected significantly deregulated pathways belonging to KEGG’s main category 
‘Environmental Information Processes’. The main category is divided into 3 subcategories. Two of the 
categories contain significantly deregulated pathways, which are shown in the table with their respective NES and 
adjusted p-values. Up-regulated pathways are indicated by the positive NES colored in red and down-regulated 
pathways are indicated by the negative NES colored in green. Comparisons were done by the respective 
conditions of diabetic (DB) or non-diabetic (NDB) rats and animals which received the light treatment (BL) or their 
control (C). 
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Conspicuously, TNF and NF-κB signaling pathways are up-regulated. Also, the 
calcium signaling pathway is up-regulated in the signal transduction. Here, MAPK 
and PI3K-Akt signaling pathway are up-regulated, too. Related to that, cytokine 
receptors and interaction seems to be affected by the long-term blue light treatment 
as well.  
 
Table 20 shows the deregulated pathways in the main category ‘Cellular Processes’, 
where cell growth and death is deregulated (full data set is shown in Table 27, 
chapter 7 Appendix). Cell cycle pathways are down-regulated, whereas apoptosis, 
necroptosis and ferroptosis are up-regulated.  
Linked to the immune response, affected pathways can be found in the subcategory 
‘Transport and catabolism’. Here, phagosome, lysosome and autophagy pathways 
are up-regulated.  
Table 20: Selected significantly deregulated pathways belonging to KEGG’s main category ‘Cellular 
Processes’. The main category is divided into 5 subcategories. Three of the categories contain significantly 
deregulated pathways, which are shown in the table with their respective NES and adjusted p-values. Up-
regulated pathways are indicated by the positive NES colored in red and down-regulated pathways are indicated 
by the negative NES colored in green. Comparisons were done by the respective conditions of diabetic (DB) or 
non-diabetic (NDB) rats and animals which received the light treatment (BL) or their control (C). 
 
Results 
73 
Up-regulated pathways that are related to the immune response can also be found in 
the main category ‘Organismal Systems’ (Table 21, full data set is shown in Table 28, 
chapter 7 Appendix) including toll-like and NOD-like receptors. Many more 
immunological pathways are up-regulated, but also pathways involved in adipocyte 
metabolism are affected. The up-regulation of lipolysis can be noticed here, and also 
the adipocytokine signaling pathway is strongly active.  
The nervous system shows effects as well, where the neurotrophin signaling pathway 
is up-regulated.  
Table 21: Selected significantly deregulated pathways belonging to KEGG’s main category ‘Organismal 
Systems’. The main category is divided into 10 subcategories. Three of the categories contain significantly 
deregulated pathways, which are shown in the table with their respective NES and adjusted p-values. Up-
regulated pathways are indicated by the positive NES colored in red and down-regulated pathways are indicated 
by the negative NES colored in green. Comparisons were done by the respective conditions of diabetic (DB) or 
non-diabetic (NDB) rats and animals which received the light treatment (BL) or their control (C). 
 
 
Even if they are connected to human diseases, pathways belonging to this main 
category were summarized in Table 22, as they could give an overview of which 
underlying effects the blue light treatment could be linked to (full data set is shown in 
Table 29, chapter 7 Appendix). Pathways of inflammatory diseases or infections as 
rheumatoid arthritis, atherosclerosis, Yersinia or human cytomegalovirus are 
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affected. The pathway of hypertrophic cardiomyopathy was up-regulated, which is 
linked to calcium sensitivity.  
Table 22: Selected significantly deregulated pathways belonging to KEGG’s main category ‘Human 
Diseases’. The main category is divided into 12 subcategories. Seven of the categories contain significantly 
deregulated pathways, which are shown in the table with their respective NES and adjusted p-values. Up-
regulated pathways are indicated by the positive NES colored in red and down-regulated pathways are indicated 
by the negative NES colored in green. Comparisons were done by the respective conditions of diabetic (DB) or 
non-diabetic (NDB) rats and animals which received the light treatment (BL) or their control (C). 
 
 
All in all, many significantly deregulated pathways could be found. Some patterns can 
be seen by comparing the different categories of affected gene sets, but mainly they 
seem to belong to the same related cellular functions. These include cell proliferation, 
cellular repair mechanisms, apoptosis and inflammatory processes.  
 
 EU project MEDILIGHT: prototype development, testing of efficacy – in vitro 3.2
and in vivo, including temperature sensor testing 
To be able to apply the findings of the previous studies on patients, a device was 
developed during the EU-project MEDILIGHT. The goal was to transfer the effects 
seen in vitro and in vivo to humans. In the following subchapter different optimization 
and improvement steps are shown, as well as solutions to problems that occurred 
during testing.  
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3.2.1 Developing the set-up of the MEDILIGHT prototype  
First MEDILIGHT prototypes consisted of boards with different numbers and 
distances between the LEDs. With XTT assays it was determined that the optimal 
distance between LEDs was 5 mm (data not shown). From these LED boards 
progress was made by constructing flexible foils with printed wiring and embedded 
LEDs. The first prototypes were tested in vitro and compared to the Philips lamp, 
(Figure 54).  
 
Figure 54: XTT results of keratinocytes irradiated with 41.40 J/cm² of blue light using the Philips lamp and 
MEDILIGHT prototypes, respectively. Assay was performed 24 h after irradiation. For experiments with 
prototypes a diffusor and spacer were included in the set-up. Data are shown as box plots with the median, upper 
and lower quartile (interquartile range (IQR)) and whiskers (1.5 x IQR). Each box plot represents n=3 plates.  
For one of the set-ups a diffusor was used to create a more homogenous field of 
irradiation, as in previous experiments a lack thereof was noticed. Also with the use 
of a spacer that creates a distance of 5 mm to the plate surface, another set-up was 
tested. Evaluation area had to be adjusted for prototype experiments, as the 
irradiated area is smaller. 
Irradiation with 41.40 J/cm² of blue light with the Philips lamp shows a significant 
decrease in metabolic activity by nearly 30% (p < 0.0001). The irradiation with 
MEDILIGHT prototype including the diffusor shows a similar effect (p < 0.0001). 
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When using the spacer with the MEDILIGHT prototype, the effect of irradiation is 
smaller with a significant decrease by 17% (p < 0.0001). 
 
For further experiments the diffusor was included into the set-up with the prototypes, 
to have stable results, comparable to the effects of the Philips lamp. Different 
irradiation times were tested to prove the efficacy of the prototype (data not shown). 
As for the use case ‘diabetic foot ulcer’ a wound dressing should be used, it was 
attempted to replace the diffusor by a wound dressing that also has the ability to 
scatter light. The use of the prototype in combination with the wound dressing E2723 
was compared to the prototype with the diffusor (Figure 55). 
 
Figure 55: XTT results of keratinocytes irradiated with 10.35 and 41.40 J/cm² of blue light using 
MEDILIGHT prototypes. Assay was performed 24 h after irradiation. Comparative experiments between set-ups 
using a diffusor and the wound dressing E2723 were performed. Data are shown as box plots with the median, 
upper and lower quartile (interquartile range (IQR)) and whiskers (1.5 x IQR). Each box plot represents n=3 
plates.  
Results show a significant increase (p < 0.0001) by 10% for metabolic activity after 
irradiation with a fluence of 10.35 J/cm² of blue light, when using the prototype with 
the diffusor. With 41.40 J/cm² of blue light a significant decrease (p < 0.0001) in 
metabolic activity is observed, which is comparable to results from previous 
experiments (Figure 54) and results from the Philips lamp. When the prototype is 
used with the wound dressing E2723, a significant increase (p < 0.0001) by 8% in 
metabolic activity is observed after irradiation with 10.35 J/cm². There is also a 
Results 
77 
significant decrease (p < 0.0001) in metabolic activity after irradiation with 
41.40 J/cm². But the extent of the decrease is lower than for all other experiments, 
accounting to a reduction by only 5%. 
While the irradiation with 10.35 J/cm² showed to be effective, irradiation with 
41.40 J/cm² had a reduced effect on cells. Therefore in future experiments, irradiation 
times had to be increased to obtain the desired effects. 
3.2.2 Temperature sensor testing in vitro and vivo 
After it was decided which components were necessary in the set-up for the 
MEDILIGHT prototype, the efficacy of the LEDs was tested. During these 
experiments it was noticed that the flexible foil was developing heat, rising so high 
that skin cells died during in vitro testing. To determine the extent of this heat 
development, experiments on a skin polymer model were performed. For that the 
skin polymer model was placed on a heating plate, with 35°C to simulate the body’s 
core temperature. The flexible LED foil was placed on top and the temperature was 
tracked over 45 min (Figure 56). 
 
Figure 56: Temperature measurement on skin polymer model during irradiation with the MEDILIGHT 
prototype. The irradiance was adjusted to 23 mW/cm² for which a duty cycle of 46% was necessary. Back 
reflector and diffusor were integrated into the set-up. The internal sensor is displayed in green, located on the 
flexible LED foil, while the two external sensors are between the wound dressing and the skin polymer model, one 
in the middle (blue) and one on the rim (red). 
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The maximum temperature on the flexible foil rises to 52°C during irradiation, while 
the temperature in the center of the skin polymer model reaches around 47°C. The 
temperature at the rim of the skin polymer model stays relatively low with a 
temperature of 42°C, compared to the center. 
One approach to overcome this problem was to cycle the irradiation by turning the 
LEDs on for 1 min, followed by 1 min off (Figure 57). 
 
Figure 57: Temperature measurement on skin polymer model during irradiation with the MEDILIGHT 
flexible LED foil. The irradiance was adjusted to 23 mW/cm² for which a duty cycle of 46% was necessary. Back 
reflector and diffusor were integrated into the set-up. Green shows the internal sensor, located on the flexible LED 
foil, while the two external sensors are between the wound dressing and the skin polymer model, one in the 
middle (blue) and one on the rim (red). A cycle mode of 1 min on and 1 min off was used. 
This approach leads to satisfying results, as a maximum temperature of only 40°C is 
reached for the internal sensor of the MEDILIGHT prototype. The cycling of the LEDs 
can also be followed by examining the results of the 2 external sensors that have the 
same pattern of increases and decreases in temperature. For the central external 
sensor the maximum temperature at the end of the measurement is 39°C and for the 
second external sensor on the rim it rises to 36°C. 
For the MEDILIGHT App an additional feature was programmed, so that the LEDs 
turn on and off automatically in dependence to the temperature. A minimal and 
maximal temperature could be chosen, which was decided to be 37°C and 40°C 
(Figure 58). 
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Figure 58: Temperature measurement on skin polymer model during irradiation with the MEDILIGHT 
flexible LED foil. The irradiance was adjusted to 23 mW/cm² for which a duty cycle of 46% was necessary. Back 
reflector and diffusor were integrated into the set-up. Green shows the internal sensor, located on the flexible LED 
foil, while the two external sensors are between the wound dressing and the skin polymer model, one in the 
middle (blue) and one on the rim (red). A cycle mode was used, where a minimum temperature of 37°C and a 
maximum temperature of 40°C were chosen. 
The curve of the flexible foil shows that the temperature of the flex foil stays between 
the assigned temperatures. Also the internal external sensor stays at a non-critical 
temperature of 39°C, as well as the second external sensor with a temperature of 
36.5°C. After this safety feature was integrated, the experiments were extended to in 
vivo testing on porcine skin. 
For the first experiments on porcine skin, 4 prototypes were attached to the flank of 
the pig. Two of these prototypes were placed over a wound dressing E2723 and fixed 
with a pocket. The two other prototypes were attached with the adhesive pocket on 
the skin surface, but without a wound dressing. One prototype of each group was 
started and the temperature tracked (Figure 59).  
The device was run in cycled mode. Nevertheless there are no cycles while 
irradiating for around 1 hour. This means that the maximum temperature that was 
adjusted to 40°C was never reached. The temperature measured at the center of the 
LED flex foil reaches a maximum of 37°C and also the temperature of the external 
sensor stays at around 36.5°C. 
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Figure 59: Temperature measurements on porcine skin with the MEDILIGHT prototype and the pocket. An 
irradiance of 23 mW/cm² was adjusted with a duty cycle of 20%. Five different sensors of the prototype are 
shown, with one central sensor and four sensors located at the rim (Sensor 1-4). The maximum temperature in 
the program was adjusted to 40°C which is indicated by the broken black line. An external sensor was placed 
under the prototype. Its temperature is represented by the broken red line. The on/off-time of the lamp is indicated 
by the discontinuous black line. 
These results show that the temperatures of the LED flex foil and on the surface of 
the skin are similar, so the sensors are able to measure the temperature correctly.  
Further tests were performed with the use of the wound dressing E2723 provided by 
URGO (developed for MEDILIGHT) (Figure 60). 
 
Figure 60: Temperature measurements on porcine skin with the MEDILIGHT prototype, wound dressing 
E2723 and the pocket. An irradiance of 23 mW/cm² was adjusted with a duty cycle of 62%. Five different 
sensors of the prototype are shown, with one central sensor and four sensors located at the rim (Sensor 1-4). The 
maximum temperature in the program was adjusted to 40°C which is indicated by the broken black line. An 
external sensor was placed under the prototype. Its temperature is represented by the broken red line.  The 
on/off-time of the lamp is indicated by the discontinuous black line. 
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The irradiation scheme looks quite different than in the previous measurement 
(Figure 59). The duty cycle had to be adjusted to 62% due to the inclusion of the 
wound dressing. Therefore the temperature rises higher compared to the previous 
graph and due to that, cycling is necessary. The cycling is indicated by the 
discontinuous black line (‘lamp on’), where the cycles are visible. Also the 
temperature is fluctuating between the maximum and minimum temperature. The 
external sensor shows a fluctuation of temperature between 36°C and 37°C. This is 
represented by the 2 horizontal broken red lines. 
The patterns were analyzed and it was found that cycles consist of 8 s on-time and 
10 s off-time at the beginning of the measurement. At the end of the experiment the 
off-time increases to 13 s, meaning that there is a slight heat build-up over time. 
Fortunately the App can compensate for that, so that in the long run the temperature 
stays stable under 40°C. 
After irradiating the skin with the different set-ups, images of the porcine skin were 
taken and compared to the images before the start of the experiment (Figure 61).  
 
 
Figure 61: MEDILIGHT prototype, visual comparison of porcine skin before and after irradiation. 
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There is no difference between the images; especially no hyperemia is visible, which 
could be a possible side effect. 
Due to the fact that the temperature on the surface of the skin is at a reasonable 
37°C, further tests with increased maximum temperature were performed. The 
maximum temperature of one of the prototypes was increased to 42°C to possibly 
increase the on-times of the cycles and therefore reduce the total treatment time 
(Figure 62).  
 
Figure 62: Temperature measurements on porcine skin with the MEDILIGHT prototype, wound dressing 
E2723 and the pocket. An irradiance of 23 mW/cm² was adjusted with a duty cycle of 62%. Five different 
sensors of the prototype are shown, with one central sensor and four sensors located at the rim (Sensor 1-4). The 
maximum temperature in the program was adjusted to 42°C which is indicated by the broken black line. An 
external sensor was placed under the prototype. Its temperature is represented by the broken red line.  The 
on/off-time of the lamp is indicated by the discontinuous black line. 
By changing the maximum temperature the cycles change as well. The on/off-cycle 
at the beginning of the measurement is 17 s on-time and 21 s off-time which changes 
to 15 s on-time and 22 s off-time towards the end of the measurement. While 
irradiating with a higher maximum temperature, the temperature measured by the 
external sensor is not rising. It stays below 37°C, with the maximum and minimum 
indicated by the broken red line. 
As the temperature is still at a tolerable level, the maximum temperature was 
increased further to 45°C (Figure 63).  
Again, the cycling scheme changes, with the on-time of 31 s and the off time 29 s. 
Still, the measured temperature of the external sensor does not seem to rise 
significantly and stays below 37°C. For this pulsing scheme the on/off-times are quite 
similar and the temperature does not exceed the specified maximum of 40°C. In 
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conclusion, it was decided that this scheme was used for in vitro tests with the 
prototype, because it does not cause overheating and is the easiest to adjust and 
calculate with. 
 
Figure 63: Temperature measurements on porcine skin with the MEDILIGHT prototype, wound dressing 
E2723 and the pocket. An irradiance of 23 mW/cm² was adjusted with a duty cycle of 62%. Five different 
sensors of the prototype are shown, with one central sensor and four sensors located at the rim (Sensor 1-4). The 
maximum temperature in the program was adjusted to 45°C which is indicated by the broken black line. An 
external sensor was placed under the prototype. Its temperature is represented by the broken red line.  The 
on/off-time of the lamp is indicated by the discontinuous black line. 
After the experiments were finished, skin samples from the irradiated area were 
taken, histological slides created and the different conditions compared (Figure 64). 
 
Figure 64: Histology of porcine skin stained with H&E. Arrows show vessels filled with blood. Images from 
control, light treated and light treated porcine skin through a wound dressing (wd) are shown. 
Results 
84 
No differences can be seen between all three images. There is no inflammation in 
irradiated skin samples, as indicated by the absence of neutrophil leukocytes. The 
epidermal layer is intact for all samples and no vasodilation can be observed, 
indicated by the arrows. 
 
After these experiments ensured that there are no safety risks, additional 
adjustments to the prototype were applied. Silicone encapsulation was added to the 
flexible LED foil to seal the LEDs from sweat and bacteria. With the encapsulation it 
becomes easier to disinfect the device, making it reusable for one patient. Also the 
battery was changed to a model with higher capacity and a copper backing was 
added, to further increase heat dissipation. As these changes were made and the 
new cycled mode of irradiation was decided upon, the efficacy of the prototype had to 
be tested again. 
3.2.3 Prototype testing – MEDILIGHT prototype in vitro 
After deciding the final set-up of the prototype and the parts that needed to be 
included, the prototypes efficacy had to be tested. With the wound dressing, the 
silicon encapsulation and the back reflector experiments using mixed cultures of 
keratinocytes and fibroblasts were performed. The experiments were conducted as 
close to reality as possible, therefore pulsed mode with on/off times of 30 s was used 
and it was irradiated through the wound dressing E2723. The results were compared 
to the results of the Philips lamp, without any additions (Figure 65). 
The results show a similar biphasic dose-response curve for the MEDILIGHT 
prototype as for the Philips lamp. For the Philips lamp the highest metabolic activity 
with a significant increase (p < 0.0001) of 5% is observed when irradiation with 
10.35 J/cm² takes place. This differs for the prototype, where the peak is reached 
when applying a dose of 20.7 J/cm² with a significant increase (p < 0.05) by 10% 
compared to the control.  
Similarly, the lowest metabolic activity is observed for 82.80, 124.20 and 
165.60 J/cm² with a significant decrease (p < 0.0001) of metabolic activity by 25% for 
the Philips lamp and by 20% for 124.20 and 165.60 J/cm² for the MEDILIGHT 
prototype. 
Therefore, the graph for the prototype is shifted to the right to higher fluences, so that 
it has to be irradiated longer or with higher power density to reach the same effects 
as for the Philips lamp. 
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Figure 65: XTT results of mixed cultures irradiated with 10.35, 20.70, 41.40, 62.10, 82.80, 124.20 and 
165.60 J/cm² of blue light using MEDILIGHT prototypes. Assay was performed 24 h after the irradiation. 
Prototype set-up included back reflector, silicon encapsulation and wound dressing E2723. As a reference 
experiments with the Philips lamp were done in parallel. Data are shown as means ± SD. Each value represents 
n=3 plates with 3 repetitions.  
As the efficacy of the prototype was proven, animal studies were conducted using the 
MEDILIGHT prototype. 
3.2.4 Long-term irradiation of diabetic and non-diabetic rats with MEDILIGHT 
prototype 
While the rats were receiving the high-caloric diet, their blood glucose concentration 
was monitored every two weeks (Figure 66).  
 
It was noted that the glucose concentration for ZDF fa/fa rats is increasing over time 
from around 150 mg/dL to 500 mg/dL. These rising glucose levels were accompanied 
by polyuria and polydipsia; therefore development of diabetes could be confirmed in 
these animals. 
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Figure 66: Blood glucose concentration of ZDF fa/fa rats to be irradiated with the MEDILIGHT prototype. 
The measurements started shortly after the arrival of the animals until the end of the experiment. Values are 
shown as means ± SD. 
During the experiment images of the wounds were taken every second day. To 
calculate the exact wound sizes in mm² from the pixels in the digital images, an open 
source image processing package based on ImageJ was used (Fiji). Wound areas 
were associated with the wound size on the first day to calculate the wound healing 
in %. Wound areas were compared between the irradiated and control rats, displayed 
in Figure 67. 
 
In the graph the wound sizes between irradiated and control animals do not show 
any significant differences, wound sizes on day 3 and day 7 seem to be even slightly, 
but not significantly, bigger for irradiated rats. The wound sizes at the end of the 
experiment are equal in size though, therefore blue light treatment does not impair 
wound healing. 
Also, no differences between non-irradiated wounds of irradiated animals and the 
control wounds of non-irradiated animals could be seen, therefore the data is not 
shown. 
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Figure 67: Wound areas displayed in % normalized to the wound area on day 1 (D = Diabetic ZDF fa/fa, 
LED = Light therapy). Rats were irradiated with 10.35 J/cm² of blue light on day 1, 3, 5, 7, 9, and 11, which is 
marked by the arrows below the graph. Both groups of animals consist of n=6 animals, data are displayed in 
means ± SD. 
From blood sampling on day 1 and day 13 plasma samples were tested for the 
concentration of different parameters (Table 23).  
Significant differences can be seen for ALT, where the values are significantly 
decreased after the experiment for control rats by 44% (p < <0.05) and for irradiated 
rats by 71% (p < 0.001). There is also a significant difference concerning ALT values 
when irradiated and control rats are compared after the experiment. The difference 
accounts to a significant decrease by 48% (p < 0.05) for irradiated rats. There is also 
a reduction in AST concentration in the plasma for both groups after the end of the 
experiments. This is only significant for irradiated rats, where the decrease amounts 
to 34% (p < 0.05). Also for GLDH the values are significantly reduced for both groups 
after the end of the experiment. For control rats the concentration is significantly 
reduced by 76% (p < 0.01) and for irradiated rats by 84% (p < 0.01). The same effect 
is observed for potassium values, where for control rats the reduction amounts to 7% 
(p < 0.05) and for irradiated rats to 8% (p < 0.01). Protein concentration is slightly 
increased for irradiated rats by 5% (p < 0.05) and sodium levels for both groups by 
approximately 30% (p < 0.05 and p < 0.001). Development of urea concentration 
follows the same pattern with a significant reduction of 19% (p < 0.001) for control 
rats and of 13% (p < 0.01) for irradiated rats. 
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Table 23: Concentration of different plasma parameters of diabetic control and irradiated rats (ZDF fa/fa) 
are listed. Samples were taken on day 1 and day 13 of the experiment from n=6 animals per group and time 
point. Samples before the start of the experiment were pooled for a baseline. Data are expressed as means ± SD. 
Values significantly different from the baseline are indicated as *p < 0.05, **p < 0.01, ***p <0.001. Significances 
are referred to the respective baseline; parameters were also compared between the two groups, significant 
values indicated by *p < 0.05, **p < 0.01, ***p <0.001. 
Plasma 
parameter 
Time point 
[days] 
ZDF fa/fa rats 
Control 
ZDF fa/fa rats 
Irradiated 
ALT 
[U/L] 
1 177 ± 94 177 ± 94 
13 99 ± 42* 52 ± 26**** 
AST 
[U/L] 
1 121 ± 83 121 ± 83 
13 84 ± 29 80 ± 43* 
Calcium 
[mmol/L] 
1 2.79 ± 0.10 2.79 ± 0.10 
13 2.84 ± 0.06 2.86 ± 0.03 
Cholesterol 
[mg/dL] 
1 141 ± 15 141 ± 15 
13 133 ± 13 133 ± 9 
Creatinine 
[mg/mL] 
1 0.21 ± 0.02 0.21 ± 0.02 
13 0.22 ± 0.01 0.22 ± 0.02 
GLDH 
[U/L] 
1 108.6 ± 102.8 108.6 ± 102.8 
13 26.0 ± 24.6** 16.8 ± 19.8** 
Phosphate 
[mmol/L] 
1 2.14 ± 0.11 2.14 ± 0.11 
13 2.13 ± 0.16 2.11 ± 0.10 
Potassium 
[mmol/L] 
1 5.09 ± 0.39 5.09 ± 0.39 
13 4.72 ± 0.25* 4.67 ± 0.18** 
Protein 
[mg/mL] 
1 65 ± 3 65 ± 3 
13 67 ± 2 68 ± 1* 
Sodium 
[mmol/L] 
1 133 ± 3 133 ± 3 
13 136 ± 3* 138 ± 1*** 
Triglycerides 
[mg/dL] 
1 465 ± 102 465 ± 102 
13 311 ± 51*** 309 ± 136** 
Urea 
[mg/dL] 
1 53.9 ± 5.3 53.9 ± 5.3 
13 43.6 ± 3.6*** 47.1 ± 4.5** 
 
Furthermore, the rat specific CRP concentration was tested (Figure 68).  
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Figure 68: CRP concentration in rat plasma determined by ELISA of control (D) and light treated groups of 
diabetic rats (D+LED) in a long-term experiment. Samples were taken on day 1, 7 and 13. Data are shown as 
box plots with the median, upper and lower quartile (interquartile range (IQR)) and whiskers (1.5 x IQR). Each box 
plot represents n=6 plasma samples. 
The results show that on day 1 of the experiment the CRP concentration is quite high 
at 0.6 mg/dL. If we compare the CRP concentrations on day 7 of the experiment, 
differences between the groups are showing: for the group receiving light therapy the 
CRP concentration is around 0.04 mg/dL higher than for the control group 
(p < 0.0661). The differences compared to day 1 are significant for both groups with 
p < 0.001. After the experiment is finished on day 13, CRP is lower compared to 
day 1 at a level of 0.2 mg/dL (p < 0.001), but nearly the same for both groups. 
 As no differences between irradiated and control animals could be seen at the end 
of the experiment, no further analysis was performed. 
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4 DISCUSSION 
 Effects of blue light irradiation on in vitro skin models  4.1
First, different in vitro models of skin, consisting of keratinocytes and fibroblasts, were 
tested in this study. The co-culture model resulted in unstable, but mostly significant 
results; however, high standard deviations were a problem. The procedure, where 
the cells were separated from the cell culture insert, was stressing the cells, leading 
to inaccurate results. To solve this problem, another skin model was tested. Instead 
of cultivating the cells and separating them by treatment with trypsin, they were 
incubated together as a mixed culture. This showed results that were more stable 
and more consistent with experiments performed on mono-cultures of the respective 
cells. 
With the fluences tested that were obtained from mono-cultures, a biphasic dose 
response curve could also be confirmed for mixed cultures. Here, irradiation with 
10.35 J/cm² of blue light led to an increase of metabolic activity and a decrease with 
41.40 J/cm². Higher doses were aimed to be used in a wound healing scenario to first 
hinder keratinocytes to close a wound prematurely, before fibroblasts could heal the 
wound from beneath. Secondly, lower doses were employed to enhance wound 
healing and trigger fibroblasts to proliferate faster and migrate faster to the wound 
site and thereby closing it.  
Results on metabolic activity obtained by XTT test were confirmed with the scratch 
wound healing assay. The scratch assay proved that blue light treatment does not 
only have an impact on the metabolic activity, but also influences cells to proliferate 
and migrate differently, in respect to the fluences used. 
After treatment with 10.35 J/cm² of blue light, keratinocytes and mixed cultures 
showed an increase in proliferation by closing the artificial wound faster than the 
control cells. In contrast to that, fibroblasts did not show this effect, but revealed a 
reduced proliferation following low dose blue light treatment. This result does not 
necessary mean that low doses of blue light enhance metabolic activity while 
reducing the proliferation in fibroblasts: differences between set-ups of XTT and 
scratch assay could be the cause of that. While for the XTT assay black 96-well 
plates were used, this was not possible for scratch assays. Bigger wells were needed 
in this experiment, but unfortunately, no black plates are available in the size of 
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12-well plates. This causes a change of irradiance for the scratch assay, compared to 
the XTT assay. When cells are irradiated in black 96-well plates, some of the light is 
absorbed by the black walls of the plates. This ensures that there is no cross-talk 
between the wells and at the same time reduces the irradiance received by the cells. 
By switching to transparent 12-well plates, no light is absorbed, leading to a higher 
irradiance, enhanced by refraction in between the wells, allowing cross-talk 89. While 
this is also true for the other set-ups without changing the outcome, it is possible that 
fibroblasts are more susceptible to these changes. Fibroblasts are known to be more 
sensitive, compared to keratinocytes 90, 91. They might therefore have a narrower 
therapeutic window concerning phototherapy while keratinocytes have a broader 
therapeutic window. When cultivated as a mixed culture, keratinocytes might level out 
the byproducts of fibroblasts (ROS) therefore leading to an increase in proliferation 
nonetheless 92. 
Treatment with 41.40 J/cm² showed the opposite effect on keratinocytes, fibroblasts 
and mixed cultures consisting thereof: XTT assays revealed a reduction in metabolic 
activity for all cell cultures as well as anti-proliferative effects, tested by the scratch 
assay. Differences could be observed concerning migration. While fibroblasts also 
migrated to the wound site, keratinocytes and mixed cultures did not express this 
behavior. Keratinocytes and mixed cultures seem to close the artificial wound 
primarily by proliferation rather than migration. This can be observed when in 
fibroblast cultures cells appear randomly in the middle, while for e.g. keratinocytes 
the cell fronts move towards each other as a whole 93-96.  
 Effects of single doses of blue light with various fluences on rats 4.2
Because in vitro studies revealed the desired results, the experiments were 
transferred to in vivo models, to test the efficacy of blue light and whether any side 
effects were occurring. For that, the ZDF fa/+ rat was chosen as a suitable model. 
This is the healthy, lean heterozygous form of rats, where the homozygous animals 
can be triggered by their feed to develop diabetes type 2 with all its side effects, 
including impaired wound healing. Single doses of blue light irradiation with different 
fluences were tested on the healthy ZDF fa/+ rats. Additionally to the fluences 
identified to change metabolic activity, migration and proliferation, an even higher 
dose of blue light with 82.80 J/cm² was included in the testing. This fluence of blue 
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light revealed an anti-bacterial effect, as tested by members of our group and is also 
confirmed by various studies 97-99. 
 
First, blood glucose measurements were performed to be able to later compare them 
to the blood glucose levels of diabetic animals. Here, the concentrations were in a 
normal range with 137 mg/dL (± 10). Then, plasma samples were extracted before 
and after treatment, to compare whether there is an effect on the parameters of full 
overview plasma profiles for liver and kidney function. 
 
Differences were observed for AST, which is an indicator for liver damage. AST was 
significantly increased for all groups post-treatment including control animals. This is 
very likely a side effect of the anesthetics used in the experiment (ketamine) which 
are known to lead to liver damage 100, 101. 
Also, cholesterol levels differ for all groups after treatment including control animals, 
which is decreased by approximately 10%. Again, the anesthetic ketamine is likely 
the reason for this decrease as it alters the lipid metabolism, having an effect on LDL 
formation 102, 103. 
A slight but significant decrease in protein levels for control rats was observed, while 
irradiated rats did not. Low protein concentrations are not only a possible indicator for 
protein malnutrition, but are also signs of inflammation and chronic disease 104, 105. 
Here, the inflammation is a result of the experimental procedure, where wounds are 
inflicted on the rats. While control rats show signs of this inflammation it is possible 
that blue light prevents or reduces inflammatory processes, independently from the 
dose.  
 
CRP concentration in plasma was determined by a rat specific ELISA. Results 
showed an increase of CRP concentration after wounding of control rats. CRP is an 
acute phase protein, which can be used to identify infections or inflammation early 
on 106. This of course results from the injury applied by the biopsy punches and is a 
normal process of wound healing. Also, rats irradiated with 82.80 J/cm² and 
41.40 J/cm² of blue light showed an increase in CRP after the treatment, meaning 
that there is no difference between irradiated and control groups. In contrast to that, 
animals irradiated with 10.35 J/cm² stand out: with lower concentration of CRP 
compared to post-experiment values, comparable to values determined before the 
Discussion 
93 
start of the experiment. CRP is an unspecific inflammatory parameter and is 
increased when an inflammation persist in an organism106. Reduction or a missing 
increase for the group irradiated with 10.35 J/cm² indicates a suppression of 
inflammatory processes. 
 
As the wounds were observed for only three days, a comparison between the wound 
sizes did not seem to be appropriate to be analysed. Therefore histological slides 
were imaged and different parameters compared. First the size of the inflammatory 
sites was determined. Results showed no significant differences due to a small 
sample size, but some trends could be determined. While wounds irradiated with 
82.80 J/cm² of blue light showed no difference to the control, an increase of the 
inflammatory site after irradiation with 10.35 J/cm² could be seen. In contrast to that, 
after irradiation with 41.40 J/cm² a decrease of the inflammatory site was observed, 
compared to the control. Concluding from that and CRP results it can be assumed, 
that irradiation with low fluences reduces the overall inflammation, but drives the 
wound healing process forward. 
 
Analysis of histology showed a decreased inflammatory site of skin tissue irradiated 
with 41.40 J/cm². Number of leukocytes per area was found to be decreased for 
82.80 J/cm².  
 
Gene expression analysis showed linear correlation by increasing number of 
pathways up-regulated of ‘Genetic Information Processing’ with increasing fluences. 
Most pathways of cellular processes were up-regulated for 10.35 J/cm² and 
41.40 J/cm². Many pathways of the categories ‘Metabolism’, ‘Organismal Systems’ 
and ‘Human Diseases’ were down-regulated for 41.40 J/cm² and 82.80 J/cm². 
 
For 10.35 J/cm² DNA replication is up-regulated, which increases cell division, 
causing the metabolic activity and cell proliferation to be increased, as seen in vitro. 
This does not comprise cell survival, as the cell cycle is up-regulated and pathways 
related to apoptosis are not affected. Some repair mechanisms are up-regulated, 
which may be caused by cellular stress. Blue light is known to increase ROS 
production107-109 which might be the trigger here. 
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Therefore p53 signaling pathway up-regulation is no surprise. It also reacts to 
oxidative stress causing cell cycle arrest, cellular senescence or apoptosis. AMPK 
signaling pathway was down-regulated. AMPK is a sensor of cellular energy status. It 
is activated when metabolic stresses are present and influence ATP production or 
consumption. As this pathway is down-regulated, activation of energy-consuming 
biosynthetic pathways takes place. In our case, only glycan biosynthesis is up-
regulated. Phagosome pathways are also up-regulated, which play a role in tissue 
remodeling and inflammation. The same holds for leukocyte transendothelial 
migration and toll-like receptor signaling pathways, which were also found to be up-
regulated. 
The combination of the affected pathways suggests that the immune response is 
enhanced artificially by the blue light. ROS production is increased, which stresses 
the cells, causing them to enhance repair mechanisms and inflammatory pathways. 
The actual damage appears “bigger than it is” or more harmful/serious to the 
organism; in turn, this leads to an increased metabolic activity and proliferation to 
heal the injury as fast as possible. This can especially be confirmed by pathways 
from the main category ‘Human Diseases’, where bacterial invasion of epithelial cells 
and systemic lupus erythematosus are up-regulated. 
 
Metabolic pathways were mostly down-regulated for 41.40 J/cm², which could be a 
reason for the effects seen in vitro with this fluence, where proliferation and metabolic 
activity is decreased. 82.80 J/cm² of blue light do not seem to cause as many down-
regulated pathways. For both of the fluences repair mechanisms are up-regulated as 
well as DNA replication. ‘Genetic Information Processing’ pathways were mostly 
found to be up-regulated. Protein production seems to be enhanced, as pathways of 
ribosomes, RNA transport, mRNA surveillance and protein processing are up-
regulated. 
Further MAPK signaling pathway is down-regulated, which are important for cell 
proliferation and migration. This might explain the effects seen in vitro, where 
metabolic activity and proliferation is down-regulated. In that sense also cAMP is 
down-regulated, which has an influence on metabolism and gene transcription. 
For higher fluences the cell cycle is up-regulated, which can occur in response to 
cellular stress to promote cell cycle arrest and enhance DNA repair. This pathway 
also activates p53 which is also found to be up-regulated. 
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Inflammatory pathways are also up-regulated, for instance, Phagosome pathways, 
which also play a central role in tissue remodeling. In contrast to that peroxisome 
pathways are down-regulated, which affect redox signaling and lipid homeostasis. 
Reason for this might be the presence of ROS. The same as for lower fluences, the 
leukocyte transendothelial migration is up-regulated, increasing inflammatory 
responses and should improve wound healing. 
Cell adhesion molecules (CAMs) are up-regulated for all fluences. They play a critical 
role in hemostasis, immune response, inflammation, brain morphology, memory and 
learning, suggesting an enhanced brain function with blue light irradiation. 
Pathways linked to Alzheimer and Parkinson disease are down-regulated for all 
fluences, suggesting an improvement with blue light treatment. Both of these 
diseases show functional impairment of the brain accompanied by daytime 
sleepiness and fatigue 55, 57. Studies proved that blue light irradiation can have a 
positive effect on sleep quality and cognitive functions in Alzheimer’s and Parkinson’s 
patients 51, 54, 56. Other studies included patients with traumatic brain injury, where 
recovery could be improved with blue light 51, 52. 
 Long-term irradiation of diabetic rats 4.3
To start long-term irradiation of these rats, the diabetic wound model was first 
established. Induction of type 2 diabetes was confirmed by steadily increased 
glucose levels, accompanied by polyuria and polydipsia. The inflicted wounds were 
observed over 13 days. Results showed that wounds irradiated with the light 
schedule over this time course started to heal faster with 10.35 J/cm² of blue light 
from day 6 onwards. The outcome was an earlier closure of 3 days compared to non-
irradiated wounds.  
Compared to that, wounds of non-diabetic rats irradiated with blue light closed faster. 
The difference could be observed already on day 2 of the experiment and was 
noticeable until day 8. Then blue light had a better effect on diabetic rats, so that the 
wounds were similar in size for the remaining 5 days. 
 
Further, plasma samples were analyzed, revealing changes due to the induction of 
diabetes. Cholesterol levels and triglyceride concentrations were increased for 
diabetic rats. As the blood is saturated with glucose, and cannot be stored as 
glycogen due to the lack of insulin, fatty acids are formed. Plasma calcium levels 
Discussion 
96 
were increased for diabetic rats as well. Increased calcium levels are associated with 
impaired glucose metabolism, which can be seen in blood glucose concentrations 
and, of course, was one of the aims here. Decreased plasma creatinine 
concentration is associated with an increased risk of type 2 diabetes 110, which was 
the case as seen in the data. Sodium concentration of diabetic rats was found to be 
decreased compared to the non-diabetic rats. Hyponatremia is associated with high 
fluid-intake (polydipsia). As this is one of the symptoms of type 2 diabetes it is 
expected for the diabetic rats. Due to the metabolic changes in diabetic rats, also the 
inorganic phosphate is increased. As diabetes is not treated, high energy phosphates 
are reduced and tissue becomes hypoxic. 
 
ELISA for rat specific CRP showed a high concentration for diabetic rats on the day 
of wound infliction. At the end of the experiment CRP is on similar levels between 
control and irradiated rats, while irradiated rats show slightly higher values. 
Differences might be small, but show that inflammation persisted longer in irradiated 
rats. 
Compared to that, non-diabetic animals had a quite low CRP concentration on day 1 
compared to diabetic rats. This concentration was slightly decreased on day 13 as 
the wounds were nearly healed and the inflammation nearly diminished.  
The difference between the two set-ups (diabetic/non-diabetic) also suggests that 
small injuries are more severe for diabetic rats and pose a higher risk to the organism 
due to the high immune response. 
 
Histologic analysis of epidermal thickness showed that while irradiated wounds were 
closed faster, the epidermis was quite thin, compared to the non-irradiated 
counterparts. Non-diabetic irradiated wounds did also close faster, but epidermal 
thickness was the same as for diabetic animals not treated with light. This means that 
while blue light irradiation enhances wound healing, it comes with repercussions of 
thinner skin at the injury site. 
Percentage of leukocytes at the inflammatory site showed that diabetic animals have 
a higher count than non-diabetic animals. This is a side effect of the metabolic 
disease, where base levels differ between healthy and sick animals. The same trend 
can be seen for the number of leukocytes on the inflammatory site, where for diabetic 
animals the number is increased, compared to healthy controls. 
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Conspicuously TNF and NF-κB pathways are up-regulated. These pro-inflammatory 
pathways are usually found to be down-regulated as PBM is often used to improve 
inflammatory conditions 111, 112. On the other hand, an increase in inflammatory 
processes might drive wound healing forward, seen in the up-regulation of 
autophagy, lysosome and phagosome pathways. Acceleration of these pathways can 
help cleansing the injured tissue faster, by removing cell debris and pathogens. Up-
regulated toll-like receptors that can recognize pathogen-associated molecular 
patterns can contribute to that, as well as up-regulated NOD-like receptor signaling 
pathway. Also MAPK adds to that, causing cell proliferation, differentiation and 
migration. Cytokine interaction and receptors were found to be up-regulated, which 
also enhances cell growth and repair processes, while restoring homeostasis.    
 
While cell cycle seems to be down-regulated after light treatment and apoptosis, 
necroptosis and ferroptosis are up-regulated, it could be assumed that cell death is 
taking place increasingly and cells proliferate slower. Studies found though, through 
FACS analysis of skin cells, that this was not the case 108 and the results show faster 
wound healing using light treatment. As ROS is produced during PBM application 107-
109 these pathways are up-regulated, but to lead to actual cell death, a certain 
threshold has to be reached, which is not the case here. 
Additionally, as in short-term irradiation of rats shows, certain cellular repair 
mechanisms are up-regulated, which may be already diminished at the end of the 
long-term irradiation and therefore cannot be found in the gene expression analysis. 
 
The nervous system seemed to be affected by blue light treatment as well. The 
neurotrophin signaling pathway was found to be up-regulated, which can enhance 
growth and survival of neural cells and therefore adding to restoring injuries 52, 53. 
 
A study suggests that PBM reduces abdominal adipose tissue inflammatory infiltrate, 
PBM could reduce inflammatory areas and significantly lower blood glucose 
levels 113. Another study suggests improvement of glucose metabolism and 
intracellular insulin pathway, parameters related to obesity, glucose tolerance and 
reduced the area of epididymal and mesenteric adipocytes 39. 
Fatty acid metabolism and other pathways linked to lipid metabolism were found to 
be down-regulated, while lipolysis and adipocytokine signaling pathways are up-
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regulated. Metabolism of carbohydrates as glycolysis and gluconeogenesis 
pathways, as well as starch and sucrose metabolism were found to be up-regulated.  
 Development of a prototype for use in diabetic patients 4.4
In the scope of the MEDILIGHT project, a device was developed, which was intended 
for use on diabetic patients with chronic wounds. Several optimization steps had to 
be taken.  
First, the efficacy of the device was proven by comparing it to the Philips BioLight, 
which was used throughout previous experiments. Due to experiments performed 
with different components, it was decided to use a diffusor, to create a homogenous 
field of irradiation. In a further step, a wound dressing was compared to the results 
with the diffusor. The wound dressing was also able to create a homogenous 
irradiation field, but decreased effects of the blue light due to decreased irradiance. 
Irradiation times had to be adjusted, so that fluences were increased and irradiation 
showed the desired outcomes in cell culture. 
 
As irradiation times were increased to compensate for the reduction of irradiance, 
temperature of the device and on the irradiated surface increased. As this could pose 
a risk of burns, temperature measurements were performed on skin polymer models. 
Without optimization maximum temperatures of 52°C were reached. 
A strategy to reduce heat build-up, irradiation cycles of 1 min were introduced. 
Breaks of 1 min in between the irradiations could already reduce the maximum 
temperature to 40°C. 
Secondly, another improvement was added. The device was programmed in such a 
way that it could measure the temperature with a sensor located on the flexible foil in 
between the LEDs and shut off and on automatically at pre-programmed 
temperatures. The range was chosen to be between 37°C and 40°C. 
With this safety precautions, animal experiments on porcine skin could be performed. 
Measurements without the wound dressing revealed a maximum temperature of 
37°C after irradiation over 1 h. This served as an alternative, in case irradiation with 
the wound dressing would lead to high temperatures. As this was confirmed to be 
safe, experiments with the wound dressing were performed. 
Experiments with the wound dressing lead to stable results, where an alternation of 
on- and off-cycles of 8 s and 13 s was identified. Visual comparison of the porcine 
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skin showed no differences before and after irradiation, proving the safety of the 
device, as no initial burns were observed.  
In further steps, the maximum temperature was increased, leading to the 
identification of acceptable cycles for in vitro testing with 30 s on- and off-time, 
respectively. 
Final examination of histological skin samples from the irradiated areas revealed no 
changes in the physiology of the skin, again, proving the safety of the device. 
 
The final set-up of the device with all of its components had to be tested again in 
vitro. XTT results showed a shift of the biphasic dose-response-curve to longer 
irradiation times/higher fluences. By application of the prototype for 20.70 J/cm² the 
proliferative effect of blue light could be enhanced in contrast to the Philips BioLight. 
Similarly, the full effect of the anti-proliferative phase was reached at 82.80 J/cm² with 
the prototype instead of the initial 41.40 J/cm² with the Philips BioLight. 
 
Finally, the device had to be tested also in vivo. In these experiments, only the 
proliferative effects were analyzed, therefore irradiation with 10.35 J/cm² took place 
only. Unfortunately, results did not show the desired effects and wound sizes did not 
change significantly for the irradiated group. Reason for this could be the small 
therapeutic window of PBM treatment. Effects of PBM can differ significantly, when 
small details are changed. For instance, precise irradiances with certain irradiation 
times have to be chosen to reach desired effects. The fluence is not the only criterion 
that is important, so it would not necessarily lead to the same outcome if lower 
irradiances are chosen and compensated for by longer irradiation times (resulting in 
the same fluence). This could have happened when new components were 
introduced: the overall fluence was the same, but irradiance was lower and irradiation 
time was increased. To be certain of this outcome, another experiment should be 
conducted, where the device is tested with the initial settings that were used in 
previous in vivo experiments.  
 Conclusion and outlook 4.5
Proliferative and anti-proliferative effects could be found for skin cells, using different 
fluences of blue light. While metabolic activity was increased, proliferation was 
decreased for fibroblasts tested by the scratch assay when irradiated with 
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10.35 J/cm² which is contradictory to each other. It is possible that by the different 
set-up with transparent instead of black plates, the fluence was increased, leading to 
an anti-proliferative effect. This should be investigated in more detail, where shorter 
irradiation times are applied.  
It could be successfully proven, that also in combination of both cell types, blue light 
irradiation could trigger the desired effects. For mixed cultures it could be further 
investigated, if and how the migration behavior of the cells is changing with the 
application of blue light. This could be achieved by staining keratinocytes and 
fibroblasts with two different dyes and observing their migration microscopically.  
The experiments could also be transferred to in vivo studies, where effects could be 
seen in the gene expression. Here, 10.35 J/cm² of blue light increases inflammation 
and repair mechanisms locally, therefore overall inflammation is decreased, seen by 
decreased CRP values. This led to a faster wound closure in the long-term study. 
Higher fluences triggered similar pathways, but did not show a delay in wound 
healing. This can be used in a clinical application, when chronic wounds should 
receive an anti-bacterial treatment, but not affecting the wound healing.  
For this a light schedule was created in this study and the corresponding device was 
developed. The efficacy and safety of the device was proven, but due to changes in 
the set-up during irradiation, the animal model did not lead to positive results. The 
set-up has to be optimized in that aspect and in vivo experiments should be repeated 
in that aspect. 
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5 SUMMARY 
In this project a therapy and a device to treat chronic wounds in diabetics were 
developed. The therapy is based on photobiomodulation using blue light. The effects 
of different doses of blue light were first tested in vitro on skin models of 
keratinocytes and fibroblasts in different models. Here, an enhanced metabolic 
activity and proliferation could be identified with 10.35 J/cm². With higher fluences 
(41.40 and 82.80 J/cm²) the opposite effect could be observed: decreased metabolic 
activity and proliferation were revealed. Further, the experiments were transferred to 
in vivo testing on rats. Also here, single blue light irradiations with different doses 
revealed different effects in dependence of the dose, as is typical for 
photobiomodulation, described as the Arndt-Schulz-curve. Effects could be seen 
regarding the CRP, showing a reduction of inflammation with lower fluences. Gene 
expression revealed changes in the inflammatory response, where certain anti-
inflammatory and pro-inflammatory pathways were deregulated. The inflammatory 
response seemed to be enhanced, driving forward the overall inflammation response. 
This could be confirmed by long-term irradiation of diabetic rats, where wounds 
treated with light therapy healed faster than non-treated wounds. Inflammatory 
pathways were deregulated, proliferation and differentiation was up-regulated, 
formation of fibers and neurons and remodeling of granulation tissue was enhanced. 
To be able to apply the findings on patients, a device was developed, which emits 
blue light. This device was tested in vitro first, where single irradiations showed the 
same effects as with the lamp used for preliminary experiments. To prevent heat 
development the device was programmed to use pulses instead of continuous 
irradiation. Thereby the heat development could be reduced from a maximum 
temperature of 52°C to 37°C with pulses of 30 s. This scheme was tested on porcine 
skin, where no negative effects could be seen. The light schedule was tested again in 
vitro, showing a shift to higher fluences to achieve the desired effects. In vivo testing 
unfortunately did not lead to positive results, probably due to involvement of a wound 
dressing, changing the homogeneity of the irradiation area. 
Nevertheless, the project led to interesting outcomes, which are ready to be applied 
in a clinical trial and could improve healing of chronic wounds. 
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7 APPENDIX 
Table 24: Complete list of significantly deregulated pathways belonging to KEGG’s main category 
‘Metabolism’. The main category is divided into 13 subcategories. Seven of these categories contain significantly 
deregulated pathways. They are depicted with their respective NES and adjusted p-values. Up-regulated 
pathways are indicated by the positive NES colored in red and down-regulated pathways are indicated by the 
negative NES colored in green. Comparisons were done by the respective conditions of diabetic (DB) or non-
diabetic (NDB) rats and animals which received the light treatment (BL) or their control (C). 
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Table 25: Complete list of significantly deregulated pathways belonging to KEGG’s main category 
‘Genetic Information Processing’. The main category is divided into 4 subcategories. All of these categories 
contain significantly deregulated pathways. They are depicted with their respective NES and adjusted p-values. 
Up-regulated pathways are indicated by the positive NES colored in red and down-regulated pathways are 
indicated by the negative NES colored in green. Comparisons were done by the respective conditions of diabetic 
(DB) or non-diabetic (NDB) rats and animals which received the light treatment (BL) or their control (C). 
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Table 26: Complete list of significantly deregulated pathways belonging to KEGG’s main category 
‘Environmental Information Processes’. The main category is divided into 3 subcategories. Two of these 
categories contain significantly deregulated pathways. They are depicted with their respective NES and adjusted 
p-values. Up-regulated pathways are indicated by the positive NES colored in red and down-regulated pathways 
are indicated by the negative NES colored in green. Comparisons were done by the respective conditions of 
diabetic (DB) or non-diabetic (NDB) rats and animals which received the light treatment (BL) or their control (C). 
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Table 27: Complete list of significantly deregulated pathways belonging to KEGG’s main category 
‘Cellular Processes’. The main category is divided into 5 subcategories. Four of these categories contain 
significantly deregulated pathways. They are depicted with their respective NES and adjusted p-values. Up-
regulated pathways are indicated by the positive NES colored in red and down-regulated pathways are indicated 
by the negative NES colored in green. Comparisons were done by the respective conditions of diabetic (DB) or 
non-diabetic (NDB) rats and animals which received the light treatment (BL) or their control (C). 
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Table 28: Complete list of significantly deregulated pathways belonging to KEGG’s main category 
‘Organismal Systems’. The main category is divided into 10 subcategories. Nine of these categories contain 
significantly deregulated pathways. They are depicted with their respective NES and adjusted p-values. Up-
regulated pathways are indicated by the positive NES colored in red and down-regulated pathways are indicated 
by the negative NES colored in green. Comparisons were done by the respective conditions of diabetic (DB) or 
non-diabetic (NDB) rats and animals which received the light treatment (BL) or their control (C). 
 
 
 
Appendix 
114 
 
Appendix 
115 
Table 29: Complete list of significantly deregulated pathways belonging to KEGG’s main category ‘Human 
Diseases’. The main category is divided into 12 subcategories. Ten of these categories contain significantly 
deregulated pathways. They are depicted with their respective NES and adjusted p-values. Up-regulated 
pathways are indicated by the positive NES colored in red and down-regulated pathways are indicated by the 
negative NES colored in green. Comparisons were done by the respective conditions of diabetic (DB) or non-
diabetic (NDB) rats and animals which received the light treatment (BL) or their control (C). 
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